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Abstract
In biomedical sciences, the increasing amount of available high through-
put data brings many challenges. The collection of such data usually
results in large number of predictor genes and few samples, possibly
also with high noise levels. Such problems are associated to the so-
called “curse of dimensionality”, i.e. the small n large p problem.
Therefore, the development and application of computational proto-
cols in bioinformatics is necessary in order to tackle these problems,
translate knowledge discovery from genome-scale studies and infer
new knowledge combining the different types of post-genomics data.
Data mining methods, including machine learning approaches, aim
to identify patterns in high-throughput data and extract information
about the underlying biological interactions.
Research questions that are discussed in this thesis are disease strati-
fication, biomarker discovery, network inference and data integration.
The methodological contributions of this thesis focus on the problem
encountered, nowadays, by clinicians where patients appearing to have
the same disease may not respond to the same treatment. First, using
supervised and unsupervised learning techniques, a machine learning
strategy based on ensembles of decision trees was used to define sub-
phenotypes based on gene expression patterns and generate potential
biomarkers for disease progression. Second, we developed a network
inference algorithm (NetCFS) that uses feature selection to select a
number of genes (n) that are highly correlated with the phenotype
of interest so as to generate n different regression problems. Third, a
“top-down” approach was implemented where gene sets corresponding
to biochemical pathways are used to develop a disease classification
framework. A multi-stage procedure was developed to uncover func-
tional modules that are closely associated to the phenotype of inter-
est and relevant to disease pathology. Phenotype-Responsive Genes
(PRGs) are identified based on non-overlapping constraints of the
classification procedure and association rules are used to estimate the
activity level of each pathway.
Applications discussed in this thesis include skin inflammation where
an integrative approach combining clinically relevant in vivo mod-
els with molecular network analysis was developed to infer disease
biomarkers and to translate the rapidly growing body of data into
knowledge usable at the bedside. Other disease cases studied involve
cancer analyses to illustrate contributions in systems medicine. Over-
all, this thesis presents methodological contributions on predictive
models based on machine learning techniques and mathematical pro-
gramming together with relevant insights in disease mechanisms and
potential treatment options.
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This chapter highlights the recent advances in genomic era that reflect on imme-
diate advances in computational biology. Principles and scientific underpinnings
of the revolution in genomic medicine are introduced and the computational chal-
lenges in biomedical research are addressed. Further, the direction of bioinfor-
matics towards the emerging areas of integrative and translation genomics aiming
at personalized medicine is outlined. Various challenges are presented and our
contribution is shown.
1.1 The Genomic Era
The availability of high-throughput technology has resulted in the sequencing of
the entire genome of many organisms (Lander et al. [2001], Venter et al. [2001],
Zimdahl et al. [2004]), an emergence that has played a pivotal role in the process
of biological discovery. In 2005, more than 200 complete genomes have been se-
quenced and made available to the research community. Powerful methods and
databases have been developed to store, accumulate and analyze large-scale se-
quenced data. Database development was the first step for better handling and
storing the available genomes. GenBank (Benson et al. [2012]), European Molec-
ular Biology Laboratory Nucleotide Sequence Database (EMBL) (Sterk et al.
1
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[2007]), and DNA Data Bank of Japan ((DDBJ) (Kodama et al. [2012]) were the
first management systems that have been developed for accumulating those data.
Novel experimental techniques, such as DNA chips (Lockhart & Winzeler [2000]),
serial analysis of gene expression (SAGE) (Powell [1998]) and DNA microarrays
(Shyamsundar et al. [2005]), were initiated to monitor genome-wide mRNA levels
by measuring the transcript abundance in a given sample within cells and tissues.
Currently, more than 140× 109 nucleotides sequences and around 20,000 ex-
periments are released in public repositories, such as DNA Data Bank of Japan
(DDBJ) and ArrayExpress (Figure 1.1A and Figure 1.1B; statistics obtained
from DDBJ1 and ArrayExpress database2, respectively). Therefore, in functional
genomics research areas, data are producing by measuring the abundance of DNA
and RNA molecules; thereby, researchers work on understanding the genetic ba-
sis of various evolutionary and biological processes. However, recently, advances
in array design and the explosion of parallel DNA sequencing technologies facil-
itate the emergence of Next Generation Sequencing (NGS), which is on its way
to replace microarrays by focusing on better understanding the genome function,
and achieving a better quantification and annotation of trascriptomes (Shendure
[2008], Wold & Myers [2008]).
In turn, the availability of whole genome sequences for various organisms and
the recent advances in innovative high-throughput technologies have emerged
different approaches and have changed our views on molecular biology. Whereas
a few years ago, scientists were working on an individual analysis of genes or
proteins, nowadays, technologies, such as genomics, transcriptomics, proteomics,
metabolomics, epigenomics, have allowed the transition from the single entity
analysis to a large-scale approach (Ge et al. [2003], Dudley & Butte [2009]).
Much of the data are compressed into understandable context so as computational
methods to better organize the information associated with these molecules. A
move on the post-genomic era is a reality and researchers are working on achiev-
ing a complete picture of the molecular mechanistic aspects of various biological
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Figure 1.1: Information about public available DNA sequence and micro arrays.
Graphs showing (A) number of nucleotide sequences that are available in DNA Data
Bank of Japan (DDJB) and (B) the microarray experiments that are released in Ar-
rayExpress database
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1.2 Transcriptomic Data
Transcriptomics is one of the tools that are used in functional genomics to get an
understanding of genes and pathways involved in complex biological systems. It
is a type of large-scale experiment that through microarray technology monitors
the expression levels of thousands of genes at the transcript level in parallel, under
a particular condition. A microarray is a glass slide on to which DNA molecules
are attached at specific locations in an order (Ziauddin & Sabatini [2001], Zhao
& Bruce [2003], Simon et al. [2005]). These locations are called spots and each
spot may contain a few million copies of identical DNA molecules that uniquely
correspond to a gene (Brazma & Vilo [2000]). The DNA in the spot may either
be genomic DNA (cDNA array) or a short area of oligonucleotide strands (oligo-
microarray). A cDNA microarray uses the ability of a given mRNA molecule to
hybridise to its original DNA coding sequence in the form of a cDNA template
spotted on an array, while oligo-arrays are hybridised with only one sample and
provide direct information about the expression levels in an mRNA (Brazma &
Vilo [2000], Duggan et al. [1999], de Saizieu et al. [1998]).
A wide range of different microarray platforms is available today (Affymetrix1,
Agilent2, Illumina3). By using this high-throughput technology, genome-wide
patterns of gene expression can be studied and it allows the identification of
candidate genes and their function in a given biological process. Genes showing
similarity in expression pattern may be functionally related or under the same
genetic control mechanism. Therefore, genome chips will pave the way for func-
tional genomics by providing information about the expression of genes in various
cell types or states as well in various diseases or treatments (e.g. how are genes
regulated and how do genes and gene products interact) (Schena et al. [1998]).
In medical studies, microarray technology is often used as a diagnostic and
prognostic tool (Mazumder & Wang [2006], Gabriele et al. [2006]). Large data
sets from different experiments can be combined together in a single database,
which allows gene expression profiles from either different samples or samples
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be used to group patients into molecularly relevant categories. This increasing use
of microarray technology for characterizing the transcriptional profile of disease
tissue samples reveal a new tool for prediction of response to treatment and for
the identification of novel therapeutic targets.
However, research in this field is challenging. Microarray data has a high
dimension of variables but available datasets usually have only a small number of
samples, due to the fact that is a cost-effective technology. Therefore, the task of
analyzing microarray data requires novel data mining methods that are capable
to handle the high dimensionality and decipher the rules in complex biological
systems. Within data mining methods, machine learning is one of the main
drivers of identifying the relevant pieces of information and extract knowledge.
Such methods offer researchers and clinicians means to understand the underlying
biology through integration of experimental data with clinical and epidemiological
parameters.
Note, that recently RNA sequencing has revolutionized the exploration of
gene expression. Advances in the deep-sequencing workflow, from sample prepa-
ration through data analysis, enable rapid profiling and deep investigation of the
transcriptome profiling. With RNA sequencing, one can characterize all tran-
scriptional activity, coding and non-coding, in any organism without a priori
assumptions. This technique has been characterized as a revolutionary tool for
transcriptomics (Wang et al. [2009]) and it has clear advantages in determining
the structure and dynamics of the transcriptome.
1.3 Systems Biology in Translational Research
The number of sequences available as well as a wealth of experimental data in re-
lation to disease is increasing rapidly; these data need to be understood, processed
and analyzed in order to reveal the principles of how the DNA controls biological
phenomena at the molecular level. Computational approaches have been devel-
oped in order to handle such enormous data influx. During the last years, research
in computational genomics uses a combination of sequence analysis, algorithms
and data mining approaches to predict protein function, to discover how proteins
interact at the cellular level and determine the rules of proteins assembling into
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different functional networks. Various methods have been developed for the anal-
ysis of datasets to find relationships (models and patterns) and to summarize the
data in novel ways that are both understandable and useful to the data owner.
Examples include linear equations, association rules, clusters, graphs, tree struc-
tures and recurrent patterns in time series (Yeh et al. [2004], Leung et al. [2010],
Sayadi et al. [2011]). Methodologies have been suggested to address network in-
ference problems, such as protein interaction networks (Tsoka & Ouzounis [2000],
Jansen et al. [2003], Sanchez Claros & Tramontano [2012]), gene regulatory net-
works (Friedman et al. [2000]) and metabolic networks (Kanehisa [2001], Tsoka
et al. [2004]). Methodologies have been employed to use Bayesian (Friedman
et al. [2000], Kim et al. [2004]) or Petri networks (Matsuno et al. [2000]) or the
prediction of edges between “similar” vertices (Pazos & Valencia [2001]). In fact,
most of these methods base their predictions on prior knowledge, which might be
based on a model of conditional dependence in the case of Bayesian networks, or
the assumption that edges should connect similar vertices. The challenge is to
use the noisy information that is available in an intelligent way to predict poten-
tially new, possibly causal, relationships taking into account missing or uncertain
information on genome data that hinders accurate cellular and disease modeling.
Thereby, since the infancy and adolescence period of the field, bioinformatics
is a fundamental core of biology and with the emergence of technological and
computational developments it has established into a key discipline within every
realm of life sciences and biological technology (Eisenberg et al. [2006], Ouzounis
[2012]).
Today, with the completion of human and model organism genomes, the role
of bioinformatics in post-genome era is “translational” (Butte [2008], Lussier &
Li [2012]). The last five years, systems biology - a biology-based interdisciplinary
study field that focuses on the systematic study of complex interactions in biolog-
ical systems - play an increasing role in accelerating the translation of knowledge
discovery from genome scale studies to effective detection, prognosis and treat-
ment of complex diseases (Ideker et al. [2001], Kirschner [2005], Doyle et al.
[2008], Vodovotz et al. [2008], Yan [2010], Fontana et al. [2012]). Translational
research aims to aid in the development of novel techniques for the integration
and transformation of clinical and biological data so as to end up in a newly
6
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found knowledge and in solutions that could be applied in a clinical setting with
potential impact on personalized medicine. These advances in personal genomics,
in turn, emerge the field of translational systems biology. Translational systems
biology (or translational bioinformatics) is a field that characterised of integrating
clinical and biological data to enable novel knowledge by identifying molecular
patterns related to a particular disease or response to treatment (Kann [2010]).
1.4 Challenges and Opportunities
It is evident that Bioinformatics plays a crucial role in translational research
for biomarker discovery to prevent, detect and treat the disease (Butte [2008]).
Development of algorithms and computational methods is intensively applied to
biological research in order to bridge the gap between this field and the clinical
applications. Different classifiers are used for the discovery of different biomark-
ers to stratify breast cancer patients according to the risk of having or not the
disease. Diagnostic tools are being developed to detect disease based on the
combination of different types of data and statistical as well network analysis is
used to predict response to treatment or disease progression (Khan et al. [2001],
Mazumder & Wang [2006], Armutlu et al. [2008], Dudley & Butte [2009]). How-
ever, despite that advances in computational biology and the huge data volume,
the great challenge is how best to integrate this information and how to translate
the insights gained from systems and network biology into clinical medicine and
clinical applications so as to achieve better treatment.
1.5 Contributions
The increasing amount of genomic, proteomic, transcriptomic, metabolomic data
brings many challenges, as discussed in section 1.4. Various types of data are
available and each provides an independent and complementary view of the whole
genome. Among them are gene expression, Single Nucleotide Polymorphism
(SNP), copy number variation (CNV), proteomic, metabolomic and environmen-
tal and demographic data. Integration of those heterogeneous data from differ-
ent sources is increasingly becoming a crucial task in understanding functions
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of different components (e.g. genes, proteins), in uncovering the mechanisms of
biological systems as well as in the diagnosis and prognosis of complex diseases.
However, in dealing with those data is tricky. Microarray data are noisy and
have missing values. The collection of those data usually results in huge number
of predictor variables/genes and few samples, i.e. the small n large p problem.
Therefore, the development of new approaches is necessary in order to tackle
with those problems, translate knowledge discovery from genome scale studies
and infer new knowledge combining the different types of post-genomic data.
The main contributions of the present thesis focus on the tasks of data integra-
tion, biomarker discovery, disease stratification and network inference. Our first
contribution, which is described in Chapter 3 concerns a procedure, based on a
”top-down” approach where functional modules are used to develop a disease clas-
sification framework (Ainali et al. [2011]). We describe the Mixed Integer Linear
Programming (MILP) mathematical model first introduced by Xu&Papageorgiou,
which we further developed in order to be able to select optimal variables/genes
that more effectively discriminate the different phenotypes (Hyperbox Decision
Model HyperDM). Due to the limitations that arise when a gene is examined
in isolation, we applied HyperDM for the first time in known functional set of
genes to enhance current procedures in disease data classification and lead to
improved pathway-to-disease associations. Phenotype-Responsive Genes (PRGs)
are established based on non-overlapping constraints of the classification proce-
dure and association rules are used to estimate the specificity level of association
of each pathway with a phenotype of interest. Second, we developed a network
inference (NetCFS) algorithm that uses feature selection to select a number of
genes that are highly correlated with the phenotype of interest so as to gener-
ate different regression models (Chapter 4). We performed large-scale evalua-
tion of feature selection techniques in binary and multi-class dataset and using
Correlation based Feature Selection (CFS) technique, our second contribution
was a method based on the identification of g correlated features to generate g
sub-problems. The third methodological contribution of this thesis focus on the
problem that clinicians encounter where different individuals respond different to
different treatments. Clinicians require a platform that will help them to rec-
ommend drug or combination of drugs for a particular patient. In Chapter 5,
8
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we propose a computational pipeline for patient stratification, using a machine
learning strategy based on ensembles of decision trees (Ainali et al. [2012]).
Besides from the above contributions, this thesis also presents an attempt to
enable the use of network biology within translational medicine proposing novel
computational pipelines applied in complex skin diseases. Integrating experi-
mental with public available data, the aim is to identify molecular signatures and
putative biomarkers associated with a complex disease. We applied a protein-
protein interaction approach in melanoma studies, where we integrate gene ex-
pression impaired in the experiments with public available databases to identify
marker genes or gene sets that plays an underlying functional role in the effect of
IgE antibody against cancer cells. Further, a co-expression approach was used to
integrate the biological models of psoriasiform inflammation developed with the
aim of determining whether the in vivo models were similar to human disease and
to determine the effects of IL-22 on disease development and progression. This
gene-gene network strategy was used to provide a better understanding of the
pathogenesis of psoriasis and identify cytokine-related functional modules that
could be useful for systematic identification of new promising cytokines (Chap-
ter 6). A novel framework combining experimental, clinical and public data was
implemented for interrogating cytokine pathways in human disease, by combining
disease relevant models and integrative network analysis.
1.6 Disclaimer






This chapter describes recent developments in machine learning approaches that
have been applied to bioinformatics and have made significant impact on the
identification of the mechanisms of various biological system components and
their structural relationship. Those techniques are valuable in understanding the
principles and dynamic global organization of complex biological networks.
In section 2.1, we focus on the world of Machine Learning (ML) by present-
ing advances in supervised (classification) and unsupervised learning (clustering)
in the context of molecular biology and medicine. Sections 2.2 and 2.3 present
Machine Learning and Feature Selection methods used in this thesis. A brief in-
troduction to Support Vector Machine (SVM), Ensemble Decision Trees (EDTs)
and K-Nearest Neighbor (KNN) algorithms as well to advances in integer opti-
mization for classification problems are presented.
2.1 Background
The exponential growth of biomedical data available and the dynamic complex-
ity of biological systems raise the importance of the use of computational meth-
ods. Machine Learning (ML) evolved from the field of artificial intelligence and
currently the goal is to identify valid, novel, potentially useful, and ultimately
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understandable hidden patterns in data (Larranaga et al. [2006]).
2.1.1 Supervised Learning
Supervised learning is the task to construct classifiers from a set of objects with
feature vectors (input - X1,...,Xn) and class labels (output - Y1,...,Ym) to learn a
function h : {X → Y } so that h(x) (hypothesis function) is a good predictor for
the corresponding value of y. A Training Sample (TS) is a list of features and
targets (xk, yk) and the training set is the set of training samples: (xk, yk);∀k =
1 → N . If the output is discrete-valued and we predict qualitative outputs, we
call it a classification problem. If the output is continuous-valued and we predict
quantitative outputs, we call it a regression problem.
Let L : Y × Y → < be a loss function, that given an instance (x, y), measures
the difference between the value h(x) predicted by the model h from the input
x, and the observed value y of the target variable. For a classification problem a
typical loss function is given:
L(y, h(x)) = I(y 6= h(x)) (2.1)
which is equal to 0, if h(x) = y and is equal to 1 if h(x) 6= y.
For the regression problem, a widely used loss function is the squared error:
L(y, h(x)) = (y − h(x))2 (2.2)
The goal of supervised learning is to predict the unknown targets of some
features in order to find a model h that minimizes the expected value of the







To achieve this, the model should optimally fit the noise contained in the
training data and lead to minimal generalization error, so as to reduce the po-
tential of overfitting or underfitting. To estimate the generalization error of a
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model either an independent dataset is used to compute the prediction error or
a technique called k-fold cross-validation is used. In the latter case, each model
is trained using the k− 1 sets of instances and tested on the remaining sets. The
generalization error is then estimated by the average prediction error over the k
parts. In the case, where k is equal to the number of instances (N), then the
procedure is called leave-one-out scheme (Frank et al. [2004], Hastie et al. [2009]).
Several supervised machine-learning techniques have been widely used to char-
acterize gene expression data and select genes associated with the trait of inter-
est (Wood et al. [2007]) or to classify different types of samples (Chopra et al.
[2010]). Wood et al (Wood et al. [2007]) proposed a novel permutation approach
to control variable selection by controlling the bias in error rates while Chopra
et al (Chopra et al. [2010]) using nine cancer datasets and five classification algo-
rithms, showed the improvement of the classification performance by using gene
pairs instead of single genes as input. Similarly, different statistical tests were
used to determine the importance of various SNPs in a disease and Support Vec-
tor Machines (SVMs) were used to to test different feature subsets and determine
the one with the highest classification accuracy resulted in identifying disease as-
sociated genes and gene-gene interactions from Genome Wide Associated Studies
(GWAS) (Zhou & Wang [2007]). More recently, various researchers evaluated the
prediction performance of different classifiers using protein networks and path-
way - based features of various datasets to predict protein structure or to exam-
ine protein-protein interactions (Chen & Liu [2005], Dutkowski & Ideker [2011],
Staiger et al. [2012]). Support Vector Machines (SVMs), Decision Trees, Ran-
dom Forest (RF), Bagging, Boosting, Nave Bayes, Logistic Regression, Artificial
Neural Networks (ANN) are some of those powerful approaches that have been
applied to an array of biomedical problems. Six of those were compared in order
to evaluate the accuracy of the prediction of protein co-complex relationships,
protein-protein interactions (PPIs) and protein co-pathway relationship, uncov-
ering the underlying performance of the different methods in different datasets
(Qi et al. [2006]). 30,000 yeast protein-protein pairs were selected to learn the
decision model and another test set of the same size was used to evaluate the
performance of the trained classifier in the context of the data set and feature
encoding used. Different success rates were yielded for all classifiers with Ran-
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dom Forest (RF) ranking as one of the two best methods for all combinations of
the features and was further used to study the importance of different biological
datasets. Statnikov and his colleagues, more recently, carried on a more compre-
hensive comparative benchmarking of SVM and RF algorithms (Statnikov et al.
[2008]). They used 10-fold cross-validation scheme and applied gene selection
methods in order to improve the performance. SVM exhibit good performance
in most of the prediction tasks, but they suggest that, with future improvements
and careful modification of the relevant classifier parameters, random forest may
perform better classification. Similarly, Artificial Neural Networks (ANN) were
also applied in diagnosis and detection of disease (Kapetanovic et al. [2004], Patel
& Goyal [2007]) due to their flexibility to detect complex nonlinear relationships
between dependent as well as independent variables.
2.1.2 Unsupervised Learning
In unsupervised learning, there are no explicit outputs or environmental evalu-
ations associated with each input; given a set of inputs, the task is to discover
patterns in the data above and beyond what would be considered pure unstruc-
tured noise (Hastie et al. [2009]). The only things that unsupervised learning
methods have to work with are the observed input patterns xi, which are often
assumed to be independent samples from an underlying unknown probability dis-
tribution Pi[x], and some explicit or implicit a priori information as to what is
important. Thus, if we suppose that (X, Y) are random variables represented
by some joint probability density P (X, Y ), then the goal is to directly infer the
properties of this probability without any prior knowledge.
Two classic examples of unsupervised learning are clustering and dimension-
ality reduction. The goal of cluster analysis is to partition the observations into
groups, so as to find multiple convex regions of the X-space that contain modes
of P (x). The goal of dimensionality reduction algorithms, such as Principal
Component Analysis (PCA), multidimensional scaling, self organizing maps, is
to identify low-dimensional parts within the X-space that represent high data
density. This provides information about the associations among the variables
and whether or not they can be considered as functions of a smaller set of la-
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tent variables. Overall, unsupervised methods try to extract structure in the
data, represent the data in a more compact way, or build a model of the data
generating process or parts thereof.
Several methods in unsupervised learning have been used in biomedical data.
Previous work include some theoretical approach of network inference by analyz-
ing methods, such as relevance network [RELNET](Meyer et al. [2007], Kaleta
et al. [2010]), CLR algorithm (Faith et al. [2007]) and ARACNE (Margolin et al.
[2006]), which depends on pairwise interactions between genes, enabling the in-
ference of large networks. Among the plethora of algorithms proposed in the
literature to solve the network inference problem, there is some that can work
on both time series and steady-state data, while others have been specifically
designed to analyse one or the other (Bansal, Belcastro et al. 2007). Thus, the
use of those techniques for network inference is envisaged to not only deal with
uncertainty in input data, but to be able to handle large and complex types of
information, such as complex biological systems.
In Hastie et al. [2009], one can find more details of supervised and unsuper-
vised learning.
2.2 Methods in Machine Learning
This thesis is focused on predictive modeling, feature selection and network in-
ference by using supervised and unsupervised techniques. Below, we describe the
methods predominantly used in this study: Support Vector Machines (SVM), En-
semble Decision Trees (EDTs), K-Nearest Neighbors (KNN) and Mathematical
Programming via Integer Optimization approaches.
2.2.1 Support Vector Machine (SVM)
Support vector machine (SVM) is a supervised learning method from the family
of kernel-based algorithms and is used for classification and regression (Risau-
Gusman & Gordon [2001], Agrawal [2003]). With respect to a given collection
of data, SVM calculates a maximal margin hyperplane using a particular math-
ematical function, namely kernel function. Kernel function maps the data in
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nonlinear separable points and exploit information about the inner products be-
tween data items. The underlying idea of SVM modeling is to find the optimal
line (or in N-dimensional space the hyperplane) that separates clusters of vectors
in such a way that cases in one category of the target variable are on one side
of the plane and cases in the other category are on the other size of the plane.
The support vectors are the vectors near the hyperplane (points in the dashed
lines in Figure 2.1). SVM classifier is robust to large number of variables, they
can learn complex classification functions efficiently and they apply principles to
avoid overfitting (Statnikov et al. [2008]). An overview of the SVM process is
presented in Figure 2.1.
Figure 2.1: Schematic representation of a linearly separable learning sample in two
dimensions. In the second graph the plain line represents the optimal hyperplane and
the dashed lines are on the margin. Points located on the margin or inside the margin
contribute to the predictive model.
The SVM classification function, F (x), is taken the form:
15
2. Fundamental Machine Learning Concepts
F (x) = w · x− b (2.4)
where w is the weight vector and b is the bias computed by SVM in the training
process. As shown in Figure 2.1, for each point xi, the following condition should
be satisfied so as to optimally separate the hyperplane and maximize the distance
from the hyperplane to the closest data points (maximize the margin):
yi(w · xi − b) ≥ 1,∀(xi, yi) ∈ D (2.5)
When xi are the closest vectors, F (x) is equal to 1 (as in Figure 2.1) and the
margin is equal to 1||w|| . For hard-margin SVM (Figure 2.1), support vectors are
the points, which are “on the margin”. Therefore, the training problem becomes







yi(w · xi − b) ≥ 1,∀(xi, yi) ∈ D (2.7)
However, not all the classification problems are linearly separable. In such
cases, soft-margin SVM (Figure 2.1) introduces a slack variable ξi, which esti-
mates and minimizes the degree of misclassification while maximizing the margin.
C is a parameter that determines the tradeoff between the margin size and the
amount of error in training.
Minimize:








yi(w · xi − b) ≥ 1− ξi,∀(xi, yi) ∈ D, ξi ≥ 0 (2.9)
During the last years, Support Vector Machines (SVMs) have been widely
used in the field of computational biology due to the global and unique solution
that can provide comparing for example with Neural Networks (NN) that suffer
from multiple local minima. In 1999, SVM classifier was applied to predicting a
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protein’s structural class from its amino acid sequence (Jaakkola et al. [1999]).
A new approach was developed (SVM−Fisher) that used a discriminative frame-
work built on top of a generic model (e.g. HMM) in order to identify remote
homologies. From the accuracy point of view, it performed better than any other
previous method. More recently, another study determines how to classify genes
according to the similarity on their switching mechanisms using the Fisher kernel
(Pavlidis et al. [2001]). The same year, Hua and Sun use SVM to perform predic-
tion of subcellular localization according to protein classes (Hua & Sun [2001]).
One year later, Zavaljevski and Reifman describe the application of SVM in order
to distinguish benign and pathologic human immunoglobulin light chains (Zaval-
jevski et al. [2002]). SVM has also been used to solve the difficult multi-class
problem of classifying a sequence of amino acids into one of many known pro-
tein structural classes (Melvin et al. [2007]). At the same time, a considerable
attention has been given to the analysis of microarray gene expression. In 2008,
linear classifiers were used to separate the data (splice sites) with hyperplanes
and SVMs as well as other related kernel methods approved that provide high
accuracy and can deal with high dimensional and large datasets (Ben-Hur et al.
[2008]). Lately, the algorithm have been used via a network based approach to
predict clinical outcome of patients and resulted in significantly improved repro-
ducibility of prediction performance across different data sets (Chen et al. [2011]).
2.2.2 Ensemble of Decision Trees (EDTs)
Tree-based methods, such as classification and regression trees (CART) (Breiman
et al. [1984]), partition the feature space into a set of rectangles and then fit a
tree structured model in each one. An example is shown in Figure 2.2. Decision
tree is grown using the training set and the process is binary; at each level, the
parent node is splitting into two daughter nodes in a recursive way. The algorithm
chooses the locally best discriminatory feature at each stage in the process. Given
a feature vector, the algorithm is looking for a feature that best separates the
data minimizing the mean impurity of the two partitions. A measurement of
impurity of each partitioning is made and the query that generates the least
impure partitions is selected. This process is applied recursively on each sub-
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Figure 2.2: Schematic representation of a decision tree using gene expression data.
Each internal node of the tree (ellipse) represents the input variables which are used to
recursively split the learning sample resulting in the terminal nodes (colored circles),
that contain the output variable. Internal nodes represent the 5 genes (input variables)
and the terminal nodes correspond to the predicted group (blue circle for group 1, red
for group 2, orange for group 3 and green for group 4). Full and semi-circles represent
the percentage of predicted group.
partition until either a homogeneous (perfect classification) or non-homogeneous
terminal nodes (the ends of the tree) will be achieved. Overall, the basic idea of
a tree classifier is to reduce as much as possible the uncertainty about the output
variable in the resulting subsets of samples, so as to capture complex interaction
structures in the data with low bias.
In machine learning, a committee of base classifiers has been shown to improve
overall prediction accuracy and can form a superior classifier compared to indi-
vidual ones (Tan & Gilbert [2003], Wang [2006]). Bagging, Boosting and Random
Forest (RF) are examples of such ensemble techniques, where a population of de-
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cision trees is first developed from the training data each with a different feature
subset, and then they are combined to form the composite predictor (Figure
2.3). In this way, these methods can achieve more accurate classification with
the increase of model complexity as well as offer higher stability and better gen-
eralization of unknown data. Therefore, ensemble algorithms, such as Ensemble
of Decision Trees (EDTs), impose regularization for effective analysis in “large p,
small n” problems which are widely found in many bioinformatics applications.
As shown in Figure 2.3, Ensemble of Decision Trees (EDTs) are grown non-
deterministically using a two-stage randomization procedure to build a large col-
lection of de-correlated trees and then averages them to achieve low variance. By
default, decision trees are suitable for the perturbation procedure applied to the
training data and as base classifiers are diverse from each other (each classifier
makes a misclassification independently)(Tsymbal A [2005]) . Bagging (Figure
2.3a) and Random Forests (Figure 2.3c) use perturbed data sets and differ-
ent feature sets for training tree classifiers while in boosting (Figure 2.3b) each
classifier is trained and combined from the samples with different classification
weights. Therefore, the greedy nature of one-step-at-a-time node splitting en-
ables trees (and hence forests) to obtain a different classification hypothesis and
the “grouping property” of trees enables to deal with correlation and interaction
among variables.
In comparison to bagging and boosting, Random Forests (RF) has been shown
to be more effective in addressing the gap between the sample size and data
dimension generated by high-throughput biological experiments (Diaz-Uriarte &
Alvarez de Andres [2006]). In this thesis, Random Forest (RF) is applied in
microarray data classification and development of random forests variants was
also implemented. The construction of random forests is described with the
pseudocode in Appendix A. Assuming that the training set is consisting of N
observations, then N cases are sampled with replacement from the original dataset
randomly (this is called “bagging”) so as, some observations will be selected more
than once, and others will not be selected. Therefore, by this selection, when the
training set for the current tree is drawn by sampling, about one-third of the cases
are left out of the sample. This set of out-of-bag data (OOB) is used to get a
running estimate of the classification error as trees are added to the forest. After
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Figure 2.3: Schematic representation of EDTs methods. (a) Bagging: bootstrap
sampling is applied to the training set (D) and different feature sets (D1, D2, ... Dm)
are used for training tree classifiers , (b) Boosting: each classifier is trained separately
and is combined from the samples with different classification weights. (c) Random
Forests: features are sampled by replacement and new features sets are used to train
different decision trees in parallel and their predictions are combined to make the overall
prediction by voting for the most popular class. (Figure adapted from Yang [2010])
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the construction of each tree using a different bootstrap sample from the original
data, only a subset of the total set of predictor variables is considered as possible
splitters for each node. The best predictors, though, will not be considered for
each split, but a predictor excluded from one split may be used for another split
in the same tree. In other words, a large number of decision trees are grown in
parallel, and their predictions are combined to make the overall prediction for the
forest by voting for the most popular class.
An important feature of Random Forest (RF) is the proximity matrix. Ran-
dom Forest (RF) proximity is determined by examining the terminal node mem-
bership of the data. If sample i and sample j both fall within the same terminal
node of a given tree, the proximity between i and j is increased by one. Summing
over all terminal nodes in a forest produces the proximity matrix, which repre-
sents the degree of similarity between sample points. After transforming the RF
proximity matrix to a dissimilarity matrix, it opens the door to many clustering
and visualization approaches for detecting data structures. Thus, these properties
of RF make it an appropriate tool for genomic data analysis and bioinformatics
research.
These unique advantages offered by ensemble methods resulted in their wide
application to many bioinformatics problems in dealing with small sample size,
high-dimensionality, and complexity data structure. Bagging and boosting meth-
ods have been initially applied to classify tumors using gene expression proles
(Ben-Hur et al. [2008], Dudoit & Fridlyand [2002]). Similarly, Tan and Gilbert
used seven publicly available datasets and proved that ensemble methods of bag-
ging and boosting are more robust and accurate in microarray data classification
comparing to single tree classifier (Tan & Gilbert [2003]). More recently, nonlin-
ear and non-parametric Random Forest approach has been successfully applied to
various problems, e.g. genetic epidemiology and microbiology, medical diagnosis
(Yang et al. [2009]), pathway clustering (Pang & Zhao [2008]) protein-protein
interactions and mapping human metabolic pathways (Macchiarulo et al. [2009]).
Pang et al. develop a Random Forests-based approach to identify how informa-
tive genes within pathways are related to each other from gene expression data
and investigate possible links between pathways that do not have a shared gene
(Pang & Zhao [2008]). Shi et al. successfully used RF unsupervised learning for
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tumor class discovery based on immunohistochemical tumor maker expression
(Shi et al. [2005]). Therefore, ensemble based classification is promising for the
microarray analysis.
2.2.3 K-Nearest Neighbor (KNN)
K-Nearest Neighbor (KNN) is one of the most straightforward instance-based
learning algorithms that require no model to be fit. Given a query instance x0,
the algorithm locates the k training points xn, n = 1, . . . , k, closest in distance
to x0, and then classify using majority vote among the k neighbors (Geva &
Sitte [1991], Hastie et al. [2009]). Training points (instances) are mapped within
an n-dimensional feature space where each of the n-dimensions corresponds to
one of the n-variables. The similarity between instances is measured using a
distance metric, such as Euclidean distance. Therefore, the objective of k-nearest
neighbors is to minimize the distance between two similarly classified instances,
while maximizing the distance between instances of different classes. Note that
choosing a more suitable distance metric for a specific dataset can improve the
accuracy of instance-based classifiers, although their major disadvantage is the
large computational time for classification.
Nearest neighbor classifiers has been applied in a number of real domains,
such as bioinformatics, and has the ability to perform well on data sets that are
not linearly separable, often giving better performance than more complex meth-
ods in many applications (Dudoit & Fridlyand [2002]). A comparison of KNN
with other classification methods has shown that the algorithm produce robust
performance results similarly with the others when is used for the classification of
tumor samples using gene expression profiles (Li et al. [2001]). Graph based KNN
is previously used in protein interaction prediction as well in protein structure
prediction (Shen & Chou [2006]).
2.2.4 Classification via Integer Optimization (CIO)
Mathematical programming (MP) makes use of recent advances in optimization
theory and has been used in applications for the efficient solution of the clas-
sification problems. Comparing with other supervised learning approaches, MP
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methods are straightforward to implement through standard modeling tools, do
not make strict assumptions about the distribution of the data analyzed and
no parameter optimization is required during the training process. Linear pro-
gramming formulations are widely used to extract patterns hidden from gene
expression data to achieve tissue classification or disease gene identification and
biomarker discovery (Niijima & Okuno [2009], Daruwala et al. [2004]). Mixed
Integer Programming classifiers (MIP) extend the classification model by adding
binary variables indicating misclassified data points and solving datasets involv-
ing a relatively small number of training samples. Glen (Glen [2001]) presented
a Mixed Integer Linear Programming (MILP) model to maximise the classifi-
cation accuracy for two-group classification problems. Later, piecewise linear
classifiers were applied to approximate nonlinear discriminant functions to im-
prove the classification performance (Glen [2003], Ryoo [2006]). Finally, in 2006,
Uney and Turkay introduced an MILP model hyper-box classifiers which has
been applied in protein fold type prediction (Y. et al. [2008]), drug classification
(Dagliyan et al. [2009], Armutlu et al. [2008]) and tumor classification (Dagliyan
et al. [2011]). More recently, Xu and Papageorgiou (Xu & Papageorgiou [2009]),
develop a completely different MILP formulation, which involves significantly
fewer binary/continuous optimisation variables and constraints and can identify
disjoint regions of the dataset through hyper-boxes with the best prediction accu-
racy. However, while there has been extensive studies undertaken in mathematical
programming (MP) approaches for discriminant and classification analysis, they
focus mainly on two-class classification techniques. Therefore, there is a need of
robust classification methods with generalization to multiple-class problems.
Formulating biomarker identication problems as MP models and finding ef-
fective methods to solve these problems are important steps in these classifica-
tion studies. Comparing with Linear Programming (LP) models and statistical
approaches, Mixed integer-programming classifiers (MIP)-based methods may
obtain better performances, while the existence of binary variables make MIP
models solve datasets involving a relatively small number of training samples.
The optimisation strategy differentiates samples that belong to multiple classes
in feature space through hyper-boxes. The objective is to minimise the misclas-
sified samples and performance of the model is improved through an iterative
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Asm ≥ Xim − LEim
2
− U(1− Es),∀s, i,m (2.11)
Asm ≤ Xim + LEim
2
+ U(1− Es),∀s, i,m (2.12)
Non Overlapping Constraints





(Yijm + Yjim) ≤ 2M − 1,∀i = 1, . . . , N − 1, j = 1 + i, . . . , N (2.14)
E, Yijm ∈ 0, 1;LEim≥0;Xim : unrestricted
where for boxes i and j on attribute m, Yijm is a binary variable demonstrating
whether box i and j overlap. Xim is the central coordinate of hyper-box i on
attribute m. LEim is the length of hyper-box i on attribute m. Es indicates
whether sample s is correctly classified. ε is defined as the small positive number
that prevents the overlap of two boxes. Parameter Asm represents the value of
sample s on attribute m. U is a suitable upper bound.
For the improvement of the model accuracy, an iterative solution procedure
is suggested and multiple boxes for each phenotype were generated. A testing
scheme is further performed where new samples are assigned to existing hyper-
boxes so as to identify their class memberships according to pathway signatures.
Thus a disease sample is allocated to a class according to the distance between
sample s and box i on attribute m, DISTs,i,m:
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DISTs,i,m = max(0, Asm − UBim, LBim − Asm),∀s, i,m (2.15)
where UBim and LBim are the upper and lower bound of the box i on at-
tribute m, respectively. They are used for extracting the association learning
rules in order to define the phenotype margins according to the expression gene
measurements within the pathway markers.
LBim = Xim − LEim
2
,∀i,m (2.16)









An extension and an application of the model of Xu and Papageorgiou (?) is
presented in Chapter 3 using a hyper-box representation (Hyperbox Decision
Model - HyperDM).
2.3 Feature Selection Methods
Large number of features and a limited number of observations in some datasets,
such as microarray data, are not useful for producing a desired learning result and
may lead the learning algorithm to overfit to the noise. Reducing the number of
features (dimensionality) is important in statistical learning; it can save storage,
computation time and increase comprehensibility (Ma & Huang [2008]). There-
fore, the implementation of feature selection methods is important and attempts
to solve this curse of dimensionality problem by selecting through different ways a
subset of features that are useful to build a good predictor (Ben-Dor et al. [2000],
Golub et al. [1999], Pan [2002]).
The objective of feature selection methods is to achieve a subset of features
(genes that are good diagnostic indicators; biomarkers), which eliminates noise
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Figure 2.4: Schematic representation of the steps of HyperDM method in a two-
dimensional three-classes example. Each color represents one class. Step 1 determines
the boundaries for corresponding classes for all samples. In Step 2, the MILP model
is applied to the training data, hyper-boxes are constructed and samples outside of the
boxes are identified. Then, one more box for each class with misclassified samples is
added (Step 3). Finally, the algorithm follows an iterative procedure by solving single
level MILPs until the objective function values of two successive iterations are the same
(Step 4)
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from the classification task, optimises classification between different classes,
avoids overfitting and provides faster and more cost-effective predictors. Filters,
wrappers, and feature weighting are the three main approaches in feature (gene)
selection. Filter methods remove features that are irrelevant with the training
data according to some prior knowledge. Wrapper approaches are dependent to
classification algorithms to evaluate the feature subsets and as a result, they have
high computational complexity. Feature weighting methods simply rank features
according to a relevant weigh. As shown in Chapter 3, the following feature
scoring functions are further emploeyd to find a small set of features (markers)
that best explains the difference between different phenotypes/conditions: Cor-
relation based-Feature Selection (CFS), Significance Attribute Evaluator, Support
Vector Machine Attribute Evaluator (SVMAttrEval) and Attribute Ranking from
Weka 1 machine learning package (Frank et al. [2004]), and Variable Importance
Metrics (VIM) derived from Ensemble of Decision Trees (EDTs) classifiers.
2.3.1 Correlation based-Feature Selection (CFS)
Correlation-based feature selection (CFS) algorithm was first introduced as a
filter method by Hall & Smith [1998]. The algorithm is based on the hypothesis
that ’a good feature subset is one that contains features highly correlated with
(predictive of) the class, yet uncorrelated with (not predictive of) each other’
(Hall & Smith [1998]). In other words, a feature is useful if it is correlated with
the class; otherwise it is irrelevant. If the correlation between each of the features
and the class is known, and the inter-correlation between each pair of features is
given, then the CFS evaluates a subset of features by estimating:
CFSs =
krcf√
k + k(k − 1)rff (2.19)
where CFSs is the score of a feature subset S containing k features, rcf is the
average of the correlations between the features and the class (f ∈ S), and rff
is the average inter-correlation between the features. The equation measures the
redundancy among the group of features and indicates the predictive ability of a
1http://www.cs.waikato.ac.nz/ml/weka/
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subset of features (Hall & Smith [1998]).
2.3.2 SVM Attribute Evaluator (SVMAttributeEval)
SVM Attribute Evaluator algorithm is a wrapper feature selection method that
evaluates the importance of a feature by using an SVM classifier. As discussed
in Section 2.2.1, a property of SVM is that the weights wi of the classification
function F (x) are a metric of a small subset of the training examples that are
closest to the decision boundary and lie on the margin, called ’support vectors’.
Therefore, in SVMAttributeEval the features are ranked by the square of the
weight assigned to them by the SVM (Guyon et al. [2002]). The algorithm is fol-
lowing an iterative procedure, which ranks features and discards the worst one,
after sub sampling of the dataset similarly like the Recursive Feature Elimination
(RFE) algorithm:
1. An SVM is created on the given data sets
2. The objective function is applied for all features (this is used as the ranking
criteria).
3. The feature with the lowest value is removed and added to the feature list
4. The SVM is recreated with the remaining features
5. The above steps are repeated for all the features
6. A list of ranked features is returned.
More details can be found in Guyon et al. [2002].
2.3.3 Variable Importance Measures (VIMs) in Ensemble
of Decision Trees (EDTs)
Ensemble of Decision Trees (EDTs) can be used to select subset of features by
estimating the importance of each predictor variable. That serves as means to
quantify the effect of each variable (i.e. gene) in discriminating among the rel-
evant class outcomes (phenotypes). The Random Forest (RF) approach serves
two fundamentally different Variable Importance Measures (VIMs): the Gini im-
portance and the permutation importance (Diaz-Uriarte & Alvarez de Andres
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[2006]). Mean decrease in accuracy is motivated from statistical permutation
tests and is based on the decrease of prediction accuracy when values of a vari-
able in a node of a tree are permuted randomly (Strobl et al. [2008]). The Gini
Index measure (GI) is derived from training of the RF classifier and is used as the
splitting criterion in the construction of the trees (Menze et al. [2009]). The Gini
Index VIM is a simple average across all the trees in the forest of the decrease in
node impurity observed using that predictor.
Naturally, a gene is likely to be diagnostic if its expression value in a disease
state is different from each expression value in a normal state (when the gene
predictive power to distinguish between different classes is high). Consequently,
there is a need to eliminate the redundant genes more effectively, to choose and
to rank them based upon their ability to distinguish between various classes of
samples. If one considers the terms “discriminative” and “inequality” to have
analogous meaning, the selection of a gene against a patient population can be
evaluated in statistical terms by the Gini coefficient (Graczyk [2007]).
2.4 Disclaimer
Well known literature has been used to compile this Chapter. As well, the book





This chapter presents the state-of-the art of disease classification using microar-
ray gene expression data. Human disease classification dates to the late 19th
century, but recently, there is a growing number of transcriptomic, metabolomic,
proteomic and genomics data identifying molecular underpinnings of many dis-
orders. Therefore, integrating all these data for probing biological systems can
guide new biological insights.
In section 3.1, we present the results of prediction performance of various
classification methods. In section 3.2, we introduce a variant mathematical ap-
proach of HyperDM (HyperBox Decision Model) for disease classification through
integer optimization. HyperDM classifier was first applied in a gene expression-
based approach and then in a pathway-based approach.
3.1 Disease Classification using Microarray Gene
Expression Data
Cellular expression patterns obtained through microarray technologies are cru-
cial in defining the mechanisms underlying different disease phenotypes (disease
states, outcomes or responses). Molecular signatures or markers are extracted
from genome-wide expression profiles by marking how well gene(s) can differenti-
ate between these disease phenotypes or between disease samples and appropriate
controls. In this context, classification of gene expression has been widely used to
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discover diagnostic markers and dissect molecular signatures of complex diseases
(Golub et al. [1999], van ’t Veer et al. [2003], Liu et al. [2005], Hwang et al. [2008]
Cun & Frohlich [2012]), that determine the disease state of samples or predict
response to therapy.
3.1.1 Introduction
One of the main challenges in computational biology is the extraction of useful
information from biological data. As described in Chapter 2, section 2.2, in
a classification problem, a set of data points is divided into classes. Given an
instance of the set, the classifier is used to assign labels to new instances accord-
ing to the value of its predictor variables and a set of decision rules. Different
classification models have been successfully applied in disease classification on
the basis of molecular profiles. In particular, supervised machine learning has
been used to great effect in numerous bioinformatics prediction methods and re-
lated applications continue to grow in biomedical literature (Jensen & Bateman
[2011]).
Expression microarrays have been widely used when studying classification al-
gorithms; to classify biological samples in a number of novel ways such as by tumor
type (Golub et al. [1999]), toxicological mode of action (Thomas et al. [2001]),
and pharmacological mechanism (Gunther et al. [2003]). For example, Golub and
his colleagues constructed the weighted voting classifier to distinguish between
two types of human acute leukemia’s: acute lymphoblastic leukemia (ALL) and
acute myeloid leukemia (AML) (Golub et al. [1999]). From a total of 6817 genes
obtained from Affymetrix GeneChip, 50 genes were selected on the basis of Signal
to Noise Ratio (SNR) in 38 training samples and a voting algorithm was applied to
classify 34 new samples in the testing data set as either AML or ALL. Tibshirani
et al. [2002] used the nearest shrunken centroid method for the multi-class predic-
tion of the small round blue cell tumors (SRBCTs) data, where a set of 43 genes
achieved comparable classification performance. Dudoit et al. compared the per-
formance of various predictors including Linear Discriminant Analysis (LDA),
Classification And Regression Trees (CART) and K-Nearest Neighbors (KNN)
using three DNA microarray data sets: a leukemia (ALL/AML) data (Golub
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et al. [1999]), a lymphoma data (Alizadeh et al. [2011]) and the 60 cancer cell
line (NCI-60 panel) data (Ross et al. [2000]). They concluded that most of the
classifiers perform similarly across data sets, with a remarkable performance of
diagonal Linear Discriminant Analysis (LDA) and K-Nearest Neighbors (KNN)
compared to more sophisticated methods such as aggregated classification trees.
Diaz-Uriarte & Alvarez de Andres [2006] investigated the use of Random Forest
(RF) for classification of microarray data and showed that an ensemble of decision
trees forest has comparable performance in multi-class data to other classifica-
tion methods, including Direct Linear Discriminant Analysis (DLDA), K-Nearest
Neighbors (KNN) and Support Vector Machine (SVM).
Therefore, a variety of statistical and machine learning methods have been
used to analyze the high dimensional data generated by high-throughput tech-
nologies for disease classification and biomarker discovery. These methods have
been shown to have clinical relevance in cancer detection for a variety of tumour
types. The purpose of this study is first to gain insight on the performance of
various classification methods, facilitate the comparison of different methods and
to investigate the effect of classification techniques on the prediction of disease
subtypes based on gene expression datasets.
3.1.2 Real and Synthetic Datasets
The classifiers discussed in Chapter 2 were applied using both model - based
synthetic data and real data with different number of classes, attributes (genes)
and observations (samples) (Table 3.1). Raw data were normalized using quantile
normalization and expression estimates were computed using the Robust Multi-
chip Average (RMA) method (Irizarry et al. [2003]). For each dataset, the first
goal was to assess the performance of classification methods. The datasets used
are the following:
• Leukaemia Dataset (Golub et al. [1999]): The dataset contains 3050 genes
subdivided in two classes: 27 samples with acute lymphoblastic leukaemia
(ALL) and 11 samples with Acute Myeloid Leukaemia (AML).
• Small Round Blue Cell Tumors (SRBCTs) (Khan et al. [2001]): The data
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consists of expression measurements on 6,567 genes (2,308 genes after filter-
ing for minimal level of expression) obtained from glass-slide cDNA microar-
rays. The tumors are classified as non-Hodgkin lymphoma (NHL), Ewing
sarcoma (EWS), neuroblastoma (NB), or rhabdomyosarcoma (RMS).
• Synthetic Dataset (Yeung & Bumgarner [2003]): The dataset consists of
four-classes, with each class represented by 20 samples and each sample
is described by 1000 gene expression profiles. This four-class classification
problem was generated by allocating a set of genes as patterned genes for
class description. Non-patterned genes from real dataset are then added.
Noise is subsequently added to represent the microarray experiments. Noise
is generated under two constraints: biological and technical. One of the
challenges the researchers faced was finding the best ratios for noise vari-
ables. To deal with this issue, the researchers created a number of datasets
with different variable values.
Table 3.1: Binary, multi-class and synthetic datasets used for the evaluation of the
classification methods
Name Type No Genes No Samples No Classes
Binary Dataset Leukemia 3051 38 2
Multi-class Dataset Cancer 2308 64 4
Synthetic Dataset Synthetic 1000 80 4
3.1.3 Evaluation and Comparison of Classification Meth-
ods
A classification procedure is performed within the datasets described in Section
3.1.2 to illustrate the potential of various methods to elucidate the concerted
actions of different genes in disease. To assess predictive performance, we trained
the following classifiers: Support Vector Machines (SVM), Random Forest (RF),
K-Nearest Neighbour (KNN), Bagging, Boosting and HyperDM. A description of
each methodology is provided in Chapter 2. The machine learning algorithms,
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such as Support Vector Machines (SVM), Random Forest (RF), K-Nearest Neigh-
bour (KNN), Bagging and Boosting, were implemented in WEKA, by LIBSVM,
Random Forest, IBK, Bagging and AdaBoost functions, respectively. The mixed
integer linear programming model (HyperDM) and the iterative solution are im-
plemented in the General Algebric Modeling System (GAMS) on a CentOS 5.2
64 bit UNIX environment using the CPLEX mixed integer optimisation solver
with 1% margin of optimality.
For the different classifier parameters, we implemented classification methods
described above and obtained the prediction performances shown in Figure 3.1.
To assess predictive performance, each classifier is trained using 10-fold cross val-
idation. This scenario was repeated 50 times and the mean prediction accuracy is
reported. Support Vector Machine (SVM) was trained using linear, polynomial,
radial and sigmoid kernel functions. Random Forest (RF) was trained building en-
semble of decision trees (EDTs) with small parameter values (depth, features and
trees) and subsequently generating a number of more complex forests. Increasing
these parameters improves the prediction but not in all the datasets. K-Nearest
Neighbour (KNN) was implemented with different K values. For the real datasets
the best results were obtained where K had the smallest value (K = 1). Because
it is more difficult for the classifier to separate instances when the number of
features is large, increasing the K value may reduce class prediction. Bagging
and Boosting were used as wrappers to other classifiers, including Random Forest
and Decision Stamp under default settings. Default settings (using random forest
and decision tree) produce good results for synthetic and binary datasets and a
higher prediction rate is observed of random forest under bagging. Interestingly,
this result is comparatively better than what is achieved using more complex
random forest classifiers. This indicates that selecting features with replacement
increases the efficiency of the algorithm. From the experiments conducted we
can also observe how the bag size effects the results obtained. Overall, Support
Vector Machine (SVM) outperform in binary datasets while Random Forest (RF)
perform well in multi-class dataset.
As shown in Figure 3.1, the well-known classifiers usually require parameter
optimization to obtain accurate results depending on the structure of the data.
In contrast, as described in Chapter 2, section 2.2.4 , HyperDM approach
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Figure 3.1: Predictive performance of (A) SVM, (B) Random Forest, (C) bagging
and boosting and (D) KNN algorithms
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does not require parameters to be optimized in order to obtain high classification
accuracies and can be used for different types of data without any modifications.
However, there is a limitation when using a dataset with large number of variables
(as in the case of microarrays) and small number of samples. The inclusion
of redundant information may weaken performance of some machine learning
algorithms. In that case, the algorithm terminates due to resource limit, may
overfit the data and cannot achieve the optimal solution (Wang et al. [2005b],
Chuang et al. [2011]). In section 3.1.4, a hybrid approach that integrates feature
selection with classification methods is introduced. This strategy could achieve
consistent prediction accuracy across different datasets (Li et al. [2004]) and assist
in a better understanding of disease mechanisms (Guyon et al. [2002]).
3.1.4 Hybrid Classification Approach through Feature Se-
lection
While predictive models could be based on the expression of more than a few
tens of genes, several reasons motivate the search for short lists of predictive
genes (biomarkers). As discussed previously, selecting a small subset of genes for
classification can improve the prediction performance, provide a reduced number
of marker genes that could be used for diagnostic purposes and assist in disease
prognosis (Wang et al. [2005b]). An important characteristic of microarray data
is the large number of genes relative to the number of samples. However, this
high dimensionality in gene space increases the computational complexity while it
usually decreases the accuracy of the classification, since usually a small number
of the genes are correlated with the phenotype of interest. Thus, a prediction
model built from thousands of available predictor variables and a relatively small
sample size can be quite unstable (Miller [2002]). This fact brings the necessity
of gene selection or gene reduction for the high dimensional gene space.
Here is proposed a robust and effective hybrid classification pipeline based on
feature selection, extraction of new predictors list and training of classifiers with
the new dataset. From a machine learning perspective, restricting the number
of variables is often a way to reduce over-fitting and can thus lead to unbiased
predictions on new samples. From a biological viewpoint, inspecting the genes
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selected in the signature may shed light on biological processes involved in the
disease, understand the molecular mechanisms of the disease and suggest novel
targets. A schematic diagram of the hybrid approach is shown in Figure 3.2.
Using as input dataset the whole gene expression matrix (g × s matrix, where
g is the number of genes and s is the number of samples), first are applied
different feature selection methods to extract predictors that better discriminate
the samples and may be more informative for the phenotypes of interest. Then, a
new expression profile matrix is generated using only the genes subset identified in
the previous step and different classifiers are trained on the new dataset. Finally,
evaluation of the classifiers is performed and if the prediction accuracy is lower
than 70%, then feature selection functions are re-applied on the expression matrix
and the new selected feature subsets are used to generate a new matrix to train the
classifier. The choice of a threshold of 70% prediction performance was applied
due to the fact that increasing the error rate, the signal to noise ratio of the model
is decreasing too, indicating more noise than signal in the experiment. It has been
shown through our experiments that performance greater than 70% results in in
a classification model with higher signal to noise ratio.
New gene expression matrices are generated using different feature selection
algorithms found in WEKA machine learning package (Frank et al. [2004]) as
well Variable Importance Metrics (VIM) generated by Random Jungle, the com-
putational and memory efficient implementation of RF (Schwarz et al. [2010]).
For efficiency purposes, we also generated random datasets, selecting 10, 25 and
50 features, respectively, to investigate the feature selection techniques. For the
generation of the random dataset, 100 permutations of samples were implemented
in Java.
In Weka, four feature selection methods were examined: (i) Correlation based
Feature Selection (CFS) (ii) Significance Attribute Evaluator, which evaluates the
importance of a feature by computing the Probabilistic Significance. (iii) Support
Vector Machine Attribute Evaluator (SVMAttrEval) and (iv) Attribute Ranking,
which rank the features based on how effective they are when we construct a
random forest. More details are described in Chapter 2, section 2.3. However,
different feature selection methods result in different gene ranking and as well in
different classification rules. Therefore it is reasonable to combine the information
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from several methods by aggregating the selections of a number of feature scoring
functions. Thus, a consensus ranking was computed according to a Markov Chain
rank aggregation method as applied elsewhere (Dutkowski & Gambin [2007]) This
method consists of gathering the top ranked genes within a specified threshold
across all datasets. The threshold of 100 was applied in all of the datasets used.
Note, that using the ranked list derived from SVM Attribute Selection method
and the Random Jungle Variable Importance, four models were constructed and
solved by selecting 10, 25, 50 and 100 features (biomarkers) respectively for fur-
ther processing.
Once the feature sets are completed, they are used to create classifiers with
different parameters. We compare and contrast the results of the original dataset
with these new reduced datasets in order to check in which cases machine learning
algorithms have an advantage over simpler procedures. Tables 3.2,3.3 and 3.4
show the accuracies achieved by the standard model (original dataset) and the
hybrid model for the binary, multi-class and synthetic dataset, respectively. In all
the tables, the classification accuracy is evaluated using SVM (sigmoid and radial
kernel functions), RF, KNN, Bagging, Boosting and HyperDM for the original
dataset (without feature selection), as well for the datasets derived after feature
selection. The experimental results show that the accuracy of microarray data
improves when variable selection is implemented comparing those without feature
selection.
A very interesting observation is that HyperDM perform well in different types
of data and the performance is comparable to other methods described above
(SVM, RF, KNN, Bagging and Boosting). In contrast, the other classification
methods, even with the application of the hybrid model, do not perform similarly
well on all the datasets. HyperDM model exhibits advantages, in terms of han-
dling disjoint sets of samples well and performing feature prioritisation through
extraction of rules that may increase prediction performance.
3.1.5 Discussion
The large dimensionality (up to several tens of thousands of genes) and the small




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































render the analysis of microarray data a new challenge of research in bioinfor-
matics (Somorjai et al. [2003]). The work described in this part of the thesis is
related to the impact of high dimensionality in supervised learning. Classifica-
tion methods using all the features do not necessarily perform well due to the
existence of many irrelevant noisy features that do not contribute to the reduc-
tion of classification error. Feature selection techniques, though, preserve the
original semantics of the variables and select a subset of them that are relevant
(Wang et al. [2005c]). Therefore, a hybrid model that integrates feature reduction
methods with evaluation algorithms can result in high predictive performance.
The experiments on the microarray datasets highlighted that the classifica-
tion accuracy achieved with different strategies is highly sensitive to the type of
data and to the precise values of the learning parameters of the algorithms. For
example, increasing the number of trees and the number of nodes in the Random
Forests method induces higher prediction performance (Figure 3.1). Thus it is
of great interest to find a way to automatically tune the parameters of the clas-
sification algorithms, to search for the best feature set or to develop an approach
that will not require parameters to optimize in order to obtain high predictive
accuracies.
An effective hybrid classification approach is implemented to investigate the
relationship between various feature reduction methods and the resulting clas-
sification performance. The hybrid model, introduced in the previous section,
is applied on publicly available data sets including leukemia, SRBCT and one
synthetic dataset. The results underline the importance of HyperDM, which per-
form well without any parameter modification and capture the variability of the
different data. In addition, this study emphasizes that various feature selection
techniques return common features varying only in their relevance score. There-
fore, a feature selection approach is proposed to enhance the robustness of the
selected predictor genes. Based on the observations of Tables 3.2, 3.3 and 3.4,
highest accuracy in classification is established when using the consensus fea-
tures comparing with the accuracy in the case of using the full feature set. This
effort might provide more biologically meaningful predictors with less false pos-
itives and more accurate diagnostics. The strong influence of different feature
reduction methods on the classification accuracy observed highlights the need for
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further investigation in the complex interaction between feature reduction and
classification.
In conclusion, the experimental results show that by employing the proposed
hybrid model fewer gene subsets needed to be selected and better classification
accuracy could be obtained. However, expression-based classification can be chal-
lenging in complex diseases due to factors such as cellular and genetic hetero-
geneity. Therefore, a more effective way to increase the discriminatory power of
a model may be to combine gene expression measurements over groups of genes
that fall within functional modules, such as pathways (Draghici et al. [2003], Sub-
ramanian et al. [2005], Tian et al. [2005], Chuang et al. [2007]). The adaptation
of these procedures to solve this problem would be an interesting direction of
future research and is discussed in the following section, section 3.2)
3.2 Pathway-based Disease Classification through
Integer Optimisation
As discussed in the previous section, among classification methods used for the
analysis of disease data are bayesian predictors, support vector machines, decision
trees and mathematical programming (Furey et al. [2000],Statnikov et al. [2008],
Armutlu et al. [2008]). The majority of such approaches are based either on
considering all genes simultaneously or a single gene at a time. However, effects
such as genetic dissimilarities across patients and cellular heterogeneity within
tissues are important hurdles in obtaining good predictive performance (Ein-
Dor et al. [2005], Lee & Tzou [2009], Symmans et al. [1995]), resulting in weak
associations among genes and decreased classification performance (Saeys et al.
[2007]). The concept of using sets of genes reflecting specific biochemical pathways
has been proposed as a promising alternative over both integrative (all-gene) or
reductionist (single-gene) analyses, so as to account for the joint effects of genes
involved in similar functional groups and, therefore, derive stronger pathway-to-
phenotype associations (Schadt [2009]).
Stemming from the above, a key challenge in disease classification studies is
the development of robust pipelines to relate genotypic information to disease
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phenotypes through known molecular interactions. Common resources to record
biochemical interactions have been used in this context, such as Gene Ontology
(GO) (Ashburner et al. [2000]), KEGG (kyoto encyclopedia of genes and genomes)
(Kanehisa et al. [2004]), Reactome (Croft et al. [2011]) and BioCarta 1. Research
activities to investigate the implication of such gene sets in disease based on
transcriptomics include the gene set enrichment analysis (GSEA) (Subramanian
et al. [2005]), the use of pathway-based random forest classification (Pang & Zhao
[2008]) and hierarchical clustering (Gatza et al. [2010]). These methods use all
member genes within each pathway and then establish the predictive power of
those modules to the disease classification problem. However, such approaches
depend heavily on pathway definitions, which may not entirely correspond to the
specific disease under study. It is, therefore, an open question for the classification
procedure to detect the gene sets that best reflect which diagnostic markers are
relevant to the phenotype of interest. In this respect, methods to determine which
gene sets correspond to particular disease class have been proposed recently and
are based on classification-driven pathway activity measures and combinatorial
boolean rules (Chuang et al. [2007]Lee et al. [2008], Vaske et al. [2010], Park et al.
[2010]).
A novel pipeline for disease data classification through a pathway-based anal-
ysis is reported. The Mixed Integer Optimisation Model (HyperDM) is extended
to classify tissue samples (breast cancer and posriasis samples) to appropriate
disease classes by separating feature space using hyper-box principles (Xu & Pa-
pageorgiou [2009]). Advantages of the proposed classification model pipeline are
(i) good descriptive power through the extraction of classification rules and (ii)
effectiveness in modeling disjoint data regions. The method presented here imple-
ments a feature selection process and the use of appropriate rules to characterize
gene sets in disease classification is also reported. Overall, this work aims to en-
hance current procedures in disease data classification through pathway gene-sets





Breast cancer is the most frequently diagnosed malignancy and has been inten-
sively studied by gene expression profiling (Cheang et al. [2008]). Psoriasis is a
systemic, inflammatory autoimmune skin disease affecting 2-3% of the world pop-
ulation (Nestle et al. [2009]). Both are complex diseases with unknown molecular
mechanisms and interesting
Breast tumor tissues of 721 patients were used from NCBI Gene Expression
Omnibus (Edgar et al. [2002]) (GEO1; GSE1561, GSE2034, GSE3494, GSE1456)
and were tested on Affymetrix platforms U133A and U133B. Each sample was
recorded as a vector of 22,215 probeset expression values, which were then mapped
to the corresponding genes for further interpretation. For psoriasis tissue samples,
two datasets were considered: the first dataset consisted of 21 biopsies from
healthy donors (NN) and 28 paired non-lesional (PN) and lesional plaque type
psoriatic patients (PP) (Yao et al. [2008]), and the second dataset comprised of 64
NN, and 58 PN and PP (Gudjonsson et al. [2010]). In the first dataset, there are
also 5 samples from psoriasis patients that only provided lesional skin biopsies.
Both datasets were acquired using HGU133plus2 Affymetrix chips. According to
the original publications, each dataset was divided into two or three populations
of distinct phenotypes defining binary and multi-class problems (Table 3.5).
Pathway-specific gene expression profiles were built from microarray measure-
ments using pathway-gene associations from KEGG database (Kanehisa et al.
[2004]) and data from the C2 functional set were used and downloaded from the
Molecular Signature Database (MSigDB database v3.0, September 2010). From
this set, the model is applied on 186 pathways that covered 5267 genes, where
not all of them could be found on the datasets, due to the various platforms used.
3.2.2 HyperBox Decision Model (HyperDM)
A multi-stage procedure is applied to integrate expression and pathway datasets
for phenotype prediction of breast cancer samples according to pathway signa-
tures (Figure 3.3). Expression profiles for m tumor samples obtained from




Table 3.5: Four independent breast cancer and two psoriasis datasets. Two binary
and four-multiclass
Dataset GEO Ref. Samples Class Samples per Class
Farmer et al. [2005] GSE1561 49 3 6 Apocrine
27 Luminal
16 Basal
Wang et al. [2005a] GSE2034 286 2 209 ER+
77 ER-
Miller et al. [2005] GSE3494 247 2 213 ER+
34 ER-
Pawitan et al. [2005] GSE1456 124 4 37 Normal like
25 Basal
15 ERBB2
62 Luminal (A, B)
Yao et al. [2008] GSE14905 77 3 21 Normal (NN)
28 peri-lesional (PN)
28 lesional(PP)
Gudjonsson et al. [2010] GSE13355 180 3 4 Normal (NN)
58 peri-lesional (PN)
58 lesional(PP)
each entry (Smk) denotes the expression level of gene k in patient m. Using
gene-to-pathway correspondence, pathway-specific tumor expression matrices are
created, where samples, features and classes are used as input to the classification
algorithm.
For the multi-class disease classification problem, Mixed Integer Linear Pro-
gramming (MILP) model was used, employing a hyper-box representation, Hy-
perDM (Xu & Papageorgiou [2009]). The model is described in Chapter 2.
The proposed mathematical model and the iterative solution was implemented in
the General Algebric Modeling System (GAMS) using the CPLEX mixed integer
optimization solver 1 with 1% margin of optimality. All experiments were run
1The CPLEX Optimizer was named for the simplex method as implemented in the C pro-
gramming language, although today it also supports other types of mathematical optimization
and offers interfaces other than just C (http://en.wikipedia.org/wiki/CPLEX).
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Figure 3.3: Schematic representation of the procedure to identify phenotype-
responsive genes and extract association rules. For each pathway, corresponding expres-
sion values of participating genes were generated for all samples. HyperDM was applied
to these pathway expression profile matrices and the association rules from hyper-boxes




locally in a parallel mode of 4 threads on a linux cluster consisting of 20 nodes
(2 x Dual Core AMD Opteron(tm) Processor 280 running at 2.4 GHz and 8GB
of DDR RAM memory, 2GB per core).
3.2.3 Identification of Phenotype-Responsive Genes (PRGs)
Within a Pathway
A variant of HyperDM was also developed and applied by minimizing the at-
tributes that contribute most on preventing the overlap of boxes that belong
to different classes. For a given pathway, a new penalty term is added to the
objective function to minimize the number of features that contribute to non-
overlapping boxes. The new objective function minimizes both misclassified sam-
ples and the number of genes that guarantee the non-overlapping of two boxes i,
j belonging to different classes.
Minimize: ∑
m




where δ is a small positive number. Using the Yijk binary variable, a subset of
genes is identified for each pathway, where each of these genes can differentiate
two disease classes, for a particular gene expression spatial domain. We refer to
this subset as “Phenotype-Responsive Genes” (PRGs) within a pathway repre-
senting the member genes that characterize the relevant phenotype. Furthermore,
for the particular phenotype-responsive gene set (PRG) association rules are de-
rived from the positioning and dimensions of the hyper-boxes, as described earlier
(Figure 3.3). In this manner, we account for joint effects of multiple genes to
the prediction and discrimination of disease phenotypes within each pathway.
Note here, that the algorithm does not take into account the size of the pathways
in order to produce the phenotype-responsive gene set (PRGs), but it uses the
binary variable Yijk, as discussed above, to determine what is important for the
specificity of each pathway.
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3.2.4 Pathway specificity in disease phenotype
For a given pathway, the identified PRGs sets are further used to train another
HyperDM model and the new dimensions were used to estimate the volume of
each box in order to infer the specificity of each pathway to a specific phenotype.
For each box, the length of any side is multiplied by itself and then the products
of the boxes that correspond to the same class are summed up. In that way,
the volume of each class per pathway is determined revealing how compact or






LEik,∀i, c, k (3.2)
where LEik is the length of the box i on attribute k. In the case of highly
unbalanced datasets in order to be unbiased on our results we normalize the











The higher the volume is the more disperse the data are, reflecting to less
specificity of the pathway to the relative phenotype. An example is shown in
Figure 3.4 where equations 3.2, 3.3 and 3.4 applied to Farmer breast cancer
dataset. Extension of this method is under development and comparison with
other similar methods, such as weighted average of pathway genes, will be done.
3.2.5 Classification Evaluation
HyperDM was trained on the 186 pathway expression profiles for each of the six
datasets using the genes involved in each pathway according to the MSigDB. To
evaluate the predictive performance of HyperDM, other classification methods
were also implemented to analyse the breast cancer and psoriasis datasets. Using
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Figure 3.4: Pathway Specificity in disease phenotype using the volume metric derived




the WEKA machine learning software (Frank et al. [2004]), Support Vector Ma-
chine (SVM) (Guyon et al. [2002]), Bagging and Random Forest (RF) (Breiman
et al. [1984]) were applied as benchmarks and trained using the features involved
in each of the pathways. Predictive power of classification methods was assessed
through a training-testing scheme where 70% of the randomly extracted samples
were used in the training set and the remainder 30% is used for testing. This
scenario was repeated 50 times and the Mean Prediction Accuracy (MPA) with
the Standard Deviation (StD) that reflects the average performance is reported.
Algorithms were trained on the pathway expression matrices and parameters
were set to the default. The performance and robustness of each classifier was
evaluated based on the Signal-to-Noise Ratio (SNR) metric, which is given by:




3.2.6 Hyper-box classification improves the discrimina-
tive power of pathway markers
Hyper-box classification was performed within gene sets corresponding to bio-
chemical pathways as defined in KEGG. Here is presented the potential of the
method to elucidate the joint effects of multiple genes within pathways to define
particular disease states.
SVM outperforms for almost all the datasets, but HyperDM is promising for
the small pathway sets (approx. up to 50 genes per pathway) while it still remains
competitive in larger pathways. This is shown for two datasets (Farmer and Gud-
jonsson), in Figrure 3.5. It is worth noting that typical biochemical pathways
usually comprise less than 50 genes, according to the KEGG database. The pre-
diction accuracy of the model was compared to other classification methods and
overall results are displayed in Figure 3.6 for all the datasets. To estimate the
robustness of the classification performance throughout the pathway in the differ-
ent methods, the Signal-to-Noise Ratio (SNR) for each model was calculated. A
robust method with low misclassification risk is expected to produce high SNR.




Figure 3.5: Prediction performance of HyperDM and comparison to other classifica-
tion techniques applied in 186 pathways for (A) Farmer and (B) Gudjonsson datasets.
Yellow line corresponds to HyperDM, red to SVM, orange to Bagging, blue to Ad-
aBoost and green to Random Forest algorithm. Left y-axis represent the prediction
performance, while right y-axis represent the number of genes included in each pathway.
Pathways are shown in x-axis.
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Figure 3.6: Comparison of different classification models across different disease
datasets. Prediction performance was calculated as the average of the prediction per-
formance estimated for each KEGG pathway separately
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Table 3.6: Signal-to-Noise Ration (SNR) for the different algorithms applied to dif-
ferent datasets
Dataset HyperDM. SVM AdaBoost Bagging RF
Farmer et al. [2005] 21.0974 21.0413 18.9177 19.2098 20.2008
Wang et al. [2005a] 17.054 18.321 13.321 14.432 18.032
Miller et al. [2005] 19.054 20.054 21.054 19.1234 20.032
Pawitan et al. [2005] 19.054 20.154 17.654 19.4356 20.234
Yao et al. [2008] 22.054 21.054 20.1254 19.023 20.456
Gudjonsson et al. [2010] 22.1342 22.123 20.0023 21.023) 20.043
From the biological perspective, this analysis yields results that are com-
parable to previous studies (Gatza et al. [2010]). For example, biochemical
pathways related to energy metabolism infer high prediction accuracy among
the basal, luminal and apocrine breast cancer classes. Fructose and Mannose
Metabolism, Glycolysis and Gluconeogenesis, Pentose Phosphate pathway, Pyru-
vate Metabolism, Neurodegenerative Disorders, JAK-STAT signaling pathway and
MAPK signaling pathway were identified as pathways with best classification ac-
curacy, indicating a strong pathway-to-phenotype interaction. Note that energy
metabolism is particularly important in cancerous cells, as it has been shown that
several pathways for energy supply have been found to activate tumour cells with
a metastatic potential (Schramm et al. [2010]). For example, it has been demon-
strated that tumours have abnormal bioenergetics and subjects with cancer can
show a systematic loss of energy involving the interaction of tumour glycolysis
and gluconeogenesis (Perumal et al. [2005]). In addition, among pathways rank-
ing on the top 30, many have been previously established as major contributors
to the oncogenesis process, including Apoptosis pathway, VEGF signaling path-
way, Wnt signaling pathway, Toll-like receptor pathway and Cell Cycle. Similar
results were extracted also using the GAGE package from bioconductor which is
a method for gene set or pathway analysis (Luo et al. [2009]).
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3.2.7 Molecular signatures within pathways through phenotype-
responsive genes (PRGs)
We extracted the maximum number of genes that separate the samples that
belong to different classes. Within each pathway, genes that best differentiate two
phenotype groups (PRGs) and have a joint impact on the disease classification,
as described previously, are shown in Table 3.7.
For each pair of classes, the HyperDM model extracts at least one or more
genes with the optimal discriminative power within the pathway. According
to Table 3.7, for example, in Farmer dataset, within Fructose and Mannose
Metabolism pathway HyperDM infers PFKM, FBP1 and TSTA3 genes out of
31 as the most differentially expressed among the three disease phenotypes. In-
terestingly, FBP1, PFKM and TSTA3 were also among the top 10 selected genes
identified by the WEKA using either SVM attribute selection, Correlation Feature
Selection (CFS) or Random Forest (RF), providing further support to our results.
FBP1, PFKM and TSTA3 have also been shown recently to be up-regulated in
cancer cells leading to ATP production (Schramm et al. [2010]). In addition, ac-
cording to Breast Cancer Database (http://www.itb.cnr.it/breastcancer/) these
genes have been previously identified to be susceptible to the disease. Gene-set
signatures were also established for the other 10 top discriminative pathways. Ta-
ble 3.7 shows various genes, previously known as promoters to the development
of cancer, identified with HyperDM predictive model within different pathways.
For instance, MYC gene has been previously shown to be prominent in basal-like
breast cancer (Chandriani et al. [2009], Cancer Genome Atlas [2012]) and this
is also confirmed from HyperDM analysis, where MYC best separates the basal
group from the other two in JAK stat signalling pathway.
The proposed HyperDM can also provide rules on how samples from different
classes are separated by the Phenotype-Responsive Genes (PRGs). It has been
illustrated that the non-overlapping genes as output from the HyperDM method
can well discriminate samples of different phenotypes. Each non-overlapping
gene can separate samples from two different classes into two disjoint regions of
expression values. Results regarding the inferred rules on how to separate different









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Farmer and Yao datasets, respectively. Taken as an example again the Fructose
and Mannose Metabolism pathway, it is notable the different effect of same genes
in the different classes. High expression of TSTA3 (10.32<TSTA3 <11.24) and
low expression of PFKM (8.72<PFKM <9.64) establish a signature specific for
apocrine tumor, while low expression of TSTA3 (8.1<TSTA3<10.13) and low
expression of FBP1 (7.27< FBP1<9.32) define the class as basal tumor. This
play a major role in the final decision of therapeutic treatment.
Similarly, in psoriasis dataset, JUN gene is found to play a major role in the
differentiation of healthy from psoriatic individuals (Table 3.7). Interestingly,
JUN gene has previously shown to play a role in keratinocyte differentiation
and be relevant in the pathogenesis of psoriasis (Rainer et al. [2005]). CXCR2,
which is shown to better discriminate lesional cases from non-lesional one in
Cytokine-Cytokine Receptor Interaction and Chemokine signalling pathway, has
been previously detected to be over-expressed in psoriatic epidermis and to play a
role in the pathogenesis of inflammatory responses (Saveria et al. [2007], Cataisson
et al. [2006]).
Within each pathway, the HyperDM achieved to identify the genes that best
differentiate two phenotypic groups (phenotype-responsive genes) and have a joint
impact on the disease progression. This result suggests that in a pathway not all
of the genes are transcriptional associated with the phenotype of interest.
3.2.8 Discussion
Classification of disease states in the context of pathway gene sets through an
integer optimisation approach was demonstrated. A data from breast cancer and
psoriasis expression profiles were used to illustrate the applicability of the method
and a comprehensive comparison with other similar methodologies showed that
HyperDM approach is competitive. A development of the original MILP formu-
lation was done to achieve a minimum number of overlapping attributes that best
differentiate the classes by preventing overlapping boxes. The findings evaluate
a pathway-based approach through mathematical programming that lead to re-
sults closely tied with the biological mechanisms of complex diseases. However, a
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































set of genes making up a pathway may be derived from conditions irrelevant to
the disease of interest. Future work can expand this approach on a more com-
plete investigation of other pathways, while in-depth investigation of prediction
rules can further aid understanding of the links between pathways or functional
modules and disease phenotype.
3.2.9 Disclaimer
I am the sole contributor of the design, development, data collection and analysis
of this work. The MILP model from Xu& Papageorgiou was previously developed,




Network Biology of Complex
Diseases
Reductionist approaches are necessary in some cases, however current practise
has indictaed that they may not be sufficient to capture important interactions
between cellular components. Networks have been used to represent biological
systems and to better understand disease mechanisms by discovering disease-
associated genes. Network inference is another data-mining technique that can
represent dependencies between variables in a dataset with a graph and can play
an important role in medicine by understanding the pathophysiology of human
diseases.
In this chapter, basic concepts in network biology will be discussed as well
applications in complex diseases. Different types of network inference methods
and brief description of molecular interaction networks will be given in section
4.1. In section 4.2, a novel application of network biology in the treatment of
melanoma will be presented. Finally, in section 4.3 a description and a small
application of a novel gene network inference approach that has been developed
using the Correlation Feature Selection algorithm (NetCFS) is introduced.
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4.1 Basic concepts in network biology
A network (G = (V,E)) is modeled by a set of objects, vertices/nodes (V ), that
are connected to each other by links or edges (E). Nodes represent the elements
of the system (e.g. genes, proteins, drugs, diseases) and the edges encode the
interactions among those components (e.g. protein-protein interactions, disease-
genes associations, gene-gene interactions, etc.). Depending on the nature of
the interactions, networks can be directed or undirected. When vertices i and
j are connected through an edge (i, j), then they are called neighbors. The
total number of vertices (N) and edges E establishes the size of the network
and identifies the number of distinct elements composing the system (Gautreau
et al. [2009]). According to the connectivity patterns in the network, highly
connected vertices represent a group, which may be functionally related and is
named network module. In that way, the network is divided into communities
and the modularity metric measures the granularity of this division. In biological
systems, as in other systems, a network is an abstract representation of a graph
that is defined by means of a an adjacency matrix (n × nmatrix) representing
which nodes are adjacent to which other nodes. Figure 4.1 illustrates a typical
biological network derived through gene expression data matrix.
The characterization of topological properties in a network is inferred through
a variety of statistical concepts, such as the degree distribution, the network di-
ameter, the clustering coefficient, the shortest path length and the betweenness.
The degree of a node (or connectivity) refers to the number of links that node
has to the other nodes. The probability that a node has exactly k links, P (k),
is obtained by estimating the number of nodes N(k) with k = 1, 2, n links and
dividing by the total number of nodes N . This is called degree distribution and
reflects the different types of networks. When the probability distribution of the
number of edges per node follows a Poisson distribution and there are no highly
connected nodes (most nodes have roughly the same numbers of links, thus there
are no hubs), the network is called random. Otherwise, when there is a number
of nodes in the network that are highly connected (hubs) and the majority of
the nodes have small number of connections, then the network follows a power-
law distribution and is called scale-free (Vazquez et al. [2004], Barabasi [2005]).
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Figure 4.1: A typical biological network of gene-gene interactions derived from a
microarray dataset. Visualisation of the basic concepts of a network/graph, as described
in the section 4.1.
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Most biological networks are scale-free and hub components play a major role in
uncovering the underlying molecular mechanisms of disease, as will also be seen
in the applications described in section 4.2.
The clustering coefficient of a node is a measure of the connection density
around a node and is given as the proportion of the observed connections between
the neighbors of the node. Clustering coefficient is given by the formula 4.1:
Ci =
2ni
ki(ki − 1) (4.1)
where ni is the number of edges connecting the ki neighbors of node i and
ki(ki−1)
2
is the total number of possible links.
The shortest series of connected edges that separates two nodes is defined as
the shortest path between these nodes. The network diameter is the maximum
length of all shortest paths between all pairs of nodes in a network. If a network
is disconnected, its diameter is the maximum of all diameters of its connected
components. The betweenness of a node quantifies the number of non-redundant
shortest paths passing through the node. Note that the network diameter and
the shortest path length distribution may indicate small-world properties of the
analyzed network (Barabasi & Oltvai [2004], ).
4.1.1 Types of biological networks
There are many different types of biological networks representing various biologi-
cal systems; protein-protein interactions, metabolic networks and gene regulatory
networks are mainly used in this thesis and discussed further here.
Protein-protein Interaction Networks
Proteins are important macromolecules of life and facilitate most biological pro-
cesses in a cell. When two or more proteins bind or act together to undertake
praticular biological functions at cellular and systems level, they interact and
generate proteome-wide physical connections (De Las Rivas & Fontanillo [2010]).
Those physical connections are essential to achieve a comprehensive knowledge of
protein interactomes that will lead to a further understanding of diseases, along
with the development of therapeutic targets.
Protein-protein interactions (PPIs) are available from multiple sources and
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there are various databases that report known human protein-protein interac-
tions (PPIs) (Table 4.1). Note here, that due to literature curation of protein
interaction data, the public databases may not agree in the interactions or pro-
teins included due to the divergent curation policies across databases (Turinsky
et al. [2010]). PPIs are represented as networks, where nodes are proteins and the
edges correspond to proteins that either physically bind to each other or share
similar functions, for example participation in the same biochemical pathway
(Yook et al. [2004]).
Table 4.1: Human protein-protein interaction databases
Number Number
Databases of of URL
proteins Interactions
HPRD 30047 39233 http://hprd.org/
CCSB interactome N/A 13944 http://interactome.dfci.harvard.edu/
DIP 3337 4540 http://dip.doe-mbi.ucla.edu
BioGRID 14519 62821 http://www.thebiogrid.org
MINT 8625 32249 http://mint.bio.uniroma2.it/mint
Metabolic Networks
A series of biochemical reactions occurring within the cell are organized into
metabolic pathways and are connected by their intermediates. In each pathway,
enzymes catalyze these biochemical reactions, transform one metabolite into an-
other and further structure a metabolic network. In such a network that models
the metabolism, nodes correspond to metabolites and enzymes, and edges are bio-
chemical reactions that convert one metabolite into another. In that way, cellular
metabolism is modeled as a large-scale organizational picture in a network-based
representation (Schuster et al. [2000], Stelling et al. [2002]).
Databases with networks of biochemical reactions are available for many or-
ganisms. Such are: Kyoto Encyclopedia of Genes and Genomes (KEGG)(Kanehisa
et al. [2004]), EcoCyc (Keseler et al. [2011]), BioCyc (Caspi et al. [2012]).
Gene Regulatory Networks (GRNs)
With the availability of complete genome sequences, the regulation of expression
of the sets of genes is encoded by Gene Regulatory Networks (GRNs). Genes are
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connected with physical or regulatory interactions and represent the causality of
developmental processes. Genes can be viewed as nodes in the network, while
interactions between genes depict the edges (Davidson & Levin [2005], Levine &
Davidson [2005]).
The characterization and understanding of gene networks from high-throughput
microarray expression data reveal global principles of gene regulation. A chal-
lenging step is how to infer those networks in order to deduce the functions for
each gene and to better understand the behavior of the complex biological sys-
tems, from gene to signaling pathway, cell or tissue level. Thereby, gene network
inference is a fundamental task and several methods have been proposed that are
described in more detail in section 4.1.2.
4.1.2 Inference methods in biological networks
The reconstruction of biological networks from high-throughput data received
enormous interest the last years. Mathematics, multivariate statistics and in-
formation science methods have been developed and applied to reconstruct gene
regulatory networks and used to better understanding these systems (Bansal et al.
[2007], Beer & Tavazoie [2004], Gardner & Faith [2005], Prakash & Tompa [2005],
Ambesi-Impiombato et al. [2006]).
Supervised and unsupervised learning are the most widely used methods in
gene network reconstruction, as described in Chapter 2. Unsupervised is based
on correlation and on mutual information, while supervised require knowledge
of regulatory interactions to be used as a training set (Madhamshettiwar et al.
[2012]). Pearson Correlation Coefficient (PCC) is used to define co-expression of
genes across the various experiments. In a co-expression network, the nodes rep-
resent the genes and the edges represent the degree of similarity in the expression














Mutual Information (MI) is used to measure the degree of indepedence be-
tween two genes (equation 4.4).
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MIij = Hi +Hj −Hij (4.3)





where p(xk) is the probability distribution of random variable x that takes on
values k.
In practical application, has been shown that MI and Pearson correlation may
yield almost identical results (Steuer et al. [2002]).
Several other approaches such as Bayesian networks (Friedman et al. [2000],
Yu et al. [2004]), and ordinary differential equations (ODEs) (di Bernardo et al.
[2005], Bansal et al. [2006]) were also used successfully to infer gene networks.
Gene network inference algorithms have been used in a wide range for microarray
data analysis and recently have started to become more “integrative” by ex-
ploiting, proteinprotein interaction data, sequence data, genomic data and others
(Workman et al. [2006]).
4.2 Protein-protein interaction networks exhibit
novel molecular signatures in melanoma treat-
ment
Network-based approaches are widely used in the context of health, disease and
biomarker discovery. For instance, different types of cancer phenotypes were in-
vestigated through the topological properties of networks (Chuang et al. [2007],
Xu et al. [2008]); pathways were identified and local structures were character-
ized for cardiovascular and infectious diseases (Sharan et al. [2005], Camargo &
Azuaje [2007]). The promise of network biology is to integrate diverse biomedical
characterizations into detailed models of underlying mechanisms and therapies
through suitable computational and mathematical formalisms.
Malignant melanoma is the most lethal form of skin cancer with an inci-
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dence of 3.1 per 100,000 and an estimate of 150,000 - 200,000 cases diagnosed
every year worldwide (Ferlay et al. [2010]). Melanoma is considered the archety-
pal immunogenic tumour, because of its associations of melanoma lesions with
considerable immune cell infiltrates (Ramirez-Montagut et al. [2003], Tjin et al.
[2011]). Temporal anti-tumoral antibody and memory B cell responses in lesions
and in patient circulation have also been reported for a number of years (Gilbert,
Karagiannis et al. 2011) (Selim, Burchette et al. 2011). However, prognostic
evaluations in melanoma remain challenging and novel diagnostic and prognos-
tic biomarkers and tools are needed to improve prediction of clinical outcomes,
guide important clinical decisions, inform choice of suitable treatment regimes
and identify patients who may benefit from particular therapies (Balch & Soong
[2008]).
Most antibodies for cancer therapy in clinical use belong to the immunoglobu-
lin G class (IgG), because IgG was reported to be the best complement activator.
However, immunoglobulin E (IgE) antibodies function through high-affinity Fc
receptors and recent studies suggest that IgE antibodies are more effective than
the corresponding IgG antibodies in eliciting anti-tumor immune responses. In
this study, was examined if and how IgE antibody may harbor functional prop-
erties against cancer cells. First, IgG1 and IgE antibodies were engineered of
the same specificity against the human high molecular weight melanoma associ-
ated antigen (HMW-MAA). In vitro investigations revealed that IgG1 and IgE
antibodies induced significant tumor cell death. Then, comparison of the ther-
apeutic efficacy of these antibodies in tumor-bearing NOD/SCID/IL-2 receptor
chain-/- mice engrafted with human lymphocytes (Figure 4.2) was done. There-
fore, by activating different families of Fc receptors on immune effector cells, we
demonstrate that: (i) different antibody classes may play a functional role against
cancer cells and (ii) IgE antibodies are superior compared to IgG1 (p<0.05) and
non-specific antibody controls (p<0.001).
The translational value of the resulting knowledge lies in synergistically com-
bining bioinformatics and lab-based research to unravel biomarkers and pathways
that can be targeted using novel therapies but also in evaluating key immunologi-
cal pathways and components in melanoma as prognostic indicators or predictors
of clinical responses to treatments. Herein, a systems analysis to identify the
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effect of IgE and IgG antibodies in the tumor was performed. The objective is to
investigate the genes and pathways that affect tumors when treated with either
antibody (IgG or IgE) to assess the functional differences and similarities.
4.2.1 Data Sources
Seven NSG mice per group were used in a model of antitumor alloimmunity
Figure 4.2. NSG mice were injected subcutaneously with 5 × 105 A375 tumor
cells on day 0. On day 5 mice were injected intravenously with 10 × 106 human
peripheral blood lymphocytes (PBLs), which were isolated from a cohort of 8
healthy volunteers Figure 4.2A. Subsequent injections of antibody treatments
were given 3 times on days 12, 18, and 25 at doses of 10 mg/kg each in 150 l
baseline (PBS). A control group was treated with 10× 106 human PBLs on day
5 and injected with 150 l of PBS on days 12, 18, and 25. Tumor growth was
monitored and measured using calipers. Tumor size (mm3) was calculated using
the following formula: mm3 = d2× (D/2), where d stands for the small diameter
of tumor and D stands for the large diameter of tumor. Experiments and data
acquisition were adapted by Dr. Panos Karagiannis, St. John’s Institute King’s
College London.
After assessing for RNA integrity, Human Ref-6 and Ref-12 BeadChips (Illu-
mina, Ambion) were used to generate RNA expression data from tumors as per
manufacturers instructions. Beadchips were scanned with a BeadArray Reader
(Illumina, San Diego, CA). Each array contains over 50000 probe sets represent-
ing approximately 40000 human genes. Data were background-subtracted then
log-transformed and quantile-normalized. The expression levels were compared
by limma method an empirical Bayesian method with a moderated t- statistic
implemented in Bioconductor and the Benjamini-Hochberg method was used to
correct for multiple testing. A gene was considered as differentially expressed if
the q-value was below 0.05 and fold change (FC) more than 1.2 and less than
-1.2.
Treatment groups IgE (MAAIgE) and IgG (MAAIgG) were compared versus
baseline (saline control, PBS). The analysis started with seven samples per group,
but due to low quality of some experimental results, some sample had to be
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removed. Comparison of the groups was followed using 4 samples for PBS group,
6 samples for IgE group and 2 samples for IgG group. For the IgE treatment
group, 1045 genes were identified as significantly modulated; 1006 genes were
over expressed in IgE (MAAIgE) and 39 under-expressed. For the IgG (MAAIgG)
group were found 559 genes to be significantly modulated; 547 over expressed in
IgG (MAAIgG) and 12 under-expressed.
Interestingly, as shown in Figure 4.3A, 510 genes found to have common
effects and were over-expressed in both IgE and IgG samples compared to the
baseline. 496 genes were prominent to IgE and only 37 were specific to IgG, show-
ing a notable impact of IgE compared to IgG in eliciting anti-tumoral immune
responses, including genes related to immune response as descrived in section
4.2.2. Figure 4.3B shows the low number of under-expressed genes found to be
common in IgE and IgG (only 8 genes common; 31 genes specific to IgE and 4
genes specific to IgG)
4.2.2 Characterization of differentially regulated genes in
samples injected with IgE and IgG antibodies
To better understand the functional role of the genes that were dysregulated in
IgE and IgG compared to baseline samples, a comprehensive functional enrich-
ment analysis was further implemented using the Database for Annotation, Visu-
alisation and Integrated Discovery (DAVID) v6.7 1. Gene Ontology (GO) terms
and over-represented pathways of the genes involved in the two groups were as-
sessed. Over-expressed genes were enriched in energy related functions as well in
energy related and signalling pathways (e.g. oxidative phosphorylation, glycoli-
sis/gluconeogenesis pathway, integration of energy metabolism, Signaling by Wnt
etc.). In contrast, down-expressed common genes included enrichment in binding
related functions and trascription regulator activity. Genes that were specific in
IgE, were found to be enriched mainly in metabolic pathways as well JAK-STAT
and chemokine signalling pathways, whereas genes that were specific to IgG an-
tibody were enriched in Insulin signalling pathway. An over-representation of
immune related processes was also discovered indicating the significance of IgE
1http://david.abcc.ncifcrf.gov/
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Figure 4.2: Humanized mice models used to identify the effects of IgE and IgG
antibodies in tumor. (A) Schematic flowchart of the experiments in Humanized mice
models of melanoma antitumor alloimmunity (B) effects of IgE and IgG in tumor growth
comparing to non-specific antibody and baseline (PBS) (n = 7 mice per group; mean
SEM tumor volume in mm3
).*P < 0.05, ***P <0.001, 2-way ANOVA with Bonferroni post-hoc test. Data
are representative of 2 experiments.
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in inducing anti-tumoral immune responses.
4.2.3 Protein-Protein interaction networks in IgE and IgG
Five broadly used databases of known human protein-protein interactions were
analysed for their screening and inclusion criteria of interactions as well as the
size of the databases (as shown in Table 4.1). BioGrid and HPRD are the largest
databases of human interactions and therefore, a protein-protein interaction net-
work from the consensus interactions of those databases was generated.
The initial interaction network contained 12719 interactions documented in
both BioGrid and HPRD databases; however our analysis focused on the dif-
ferentially expressed genes identified in IgE and IgG in our experiments. There
were 1172 interactions that link 1110 nodes in the commonly expressed genes
as explained above (Figure 4.4A). 1226 protein-protein interactions with 1162
nodes were identified in the specific to IgE genes (Figure 4.4B), whereas there
were only 65 interactions linking 80 nodes in the protein-protein interaction net-
work derived from IgG specific genes (Figure 4.4C). To further examine the
association of the differentially expressed genes with the network, the up- and
downregulated genes were mapped onto the network and colored them by red
and green, respectively (Figure 4.4). In these networks, hub proteins seem to
play significant role since in the majority are observed as up-regulated in the ex-
periments and are communicating with many other up-regulated proteins being
over-represented.
To evaluate the statistical significance of the IgE, IgG specific and common
networks, randomized networks were generated by reshuﬄing edges in the original
network while preserving the degrees of the respective nodes. The number of
rewiring edges taken for each model was 4× (numberofedges) and the procedure
was repeated 300 times. The simulation showed that on average, the three random
networks contained small number of nodes proving the statistical significance of
the identified hubs in each of the real networks. In other words, nodes in the
randomised networks exhibit low number of connections, low degree nodes.
Therefore, as shown in Figure 4.5, the analysis exhibited that the network
follow a power law distribution, which is consistent with a “scale free network”
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Figure 4.3: Venn diagram representing the number common and different genes being
(A) over-expressed and (B) under-expressed in IgE and IgG samples comparing to PBS
(baseline).
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reported for most biological networks analyzed to date (Barabasi & Oltvai [2004];
see section 4.1). It is also notable that the R-squared values, which range
between 0.7-0.9 also supported the view that the networks are scale-free (Figure
4.5). The R-squared value for the degree distribution is highest for the network
specific to IgE (Figure 4.5B) indicating higher correlation and a stronger linear
relationship between the data variables.
Furthermore, in order to examine the network topology, the topological pa-
rameters, like average clustering coefficient, average degree, network diameter
and density, were assessed (Table 4.2). The protein-protein interaction network
that derived from IgE specific genes has the largest diameter and the clustering
coefficient is also higher (19 and 0.018, respectively) compared to the others. In
addition, the density metric for this network appears to be small displaying the
compactness of the graph (Table 4.2). This highlight a structured graph that
also depicts the possibility that local network topology might be driven by bio-
logical relationships between proteins and illustrates the possible biological effect
of IgE in the pathophysiology of melanoma against tumor growth. Intriguingly,
this hierarchical architecture of our network suggests also the existence of small,
highly connected, topological modules with discrete functions as shown in the
next section (Ravasz et al. [2002]).
Table 4.2: Topological parameters of protein-protein interaction networks
Networks Nodes Edges Average Diameter Density Clustering
Degree Coefficient
Common 1110 1172 2.111 17 0.0019 0.015
IgE specific 1162 1226 2.110 19 0.0018 0.018
IgE specific 80 65 1.625 4 0.0206 0
4.2.4 Discovery of biologically functional modules in PPI
networks
Louvain method was implemented for identifying communities in our networks.
The method is a greedy optimization approach that first looks for small com-
munities by optimizing modularity locally and then iteratively aggregates nodes
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Figure 4.4: Protein-protein interaction networks for (A) the common up and down
regulated genes, (B) up and down-regulated genes specific to IgE comparing to baseline
samples and (C) up and down-regulated genes specific to IgG comparing to baseline
samples. Red spots correspond to over-expressed genes while green spots correspond
to under-expressed ones.
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Figure 4.5: Power-law node degree distribution for the three protein-protein interac-
tion networks. (A) common up and down regulated genes, (B) up and down-regulated
genes specific to IgE comparing to baseline samples and (C) up and down-regulated
genes specific to IgG comparing to baseline samples. A scale free topology is shown
where there is a decrease in degree distribution with an increase in the number of links.
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belonging to the same community and builds a new network whose nodes are
the communities (Subelj & Bajec [2011]). In the IgE specific PPI network, 128
modules were found (Figure 4.6A) and further the functional enrichment of the
largest clusters was examined.
Two of the largest groups that were constructed are shown in Figure 4.6B,
which is consisting of 85 nodes of which the 16 found to be over or under ex-
pressed in the experiments. These clusters are enriched in Fc receptor signalling
(i.e. FcRI, FcR) therefore, validating the hypothesis that anti-tumour activity is
immune mediated; furhter investigation of their downstream functions was also
done. Interestingly, the kinase PTK2 (p-value=0.01) which is connected to Fc
signalling is up-regulated in IgE treated mice and according to Figure 4.6B is
connected with GSK3B which is directly interacting with NFKB1. Therefore,
this kinase is indirectly connected with NFKB1 and does regulate the IgE medi-
ated tumour killing in vitro. Note here, that PTK2 is also indirectly connected
with SOS1 (which is under-expressed in our experiments and involved in Fc ep-
silon RI signalling pathway) via NCK2, CRK and FYN. In vitro functional assays
validated that inhibition of PTK2 in monocytes reduces their potential to induce
antibody depended cytotoxicity (Figure 4.7). Analysing the phosphorylation
of PTK2 from primary monocytes that were used in an ADCC/ADCP assay to
induce tumour death, was found that IgE mediated cell death was inducing the
phosphorylation of PTK2. Further blocking PTK2 activity in primary monocytes
with the kinase inhibitor PF-431396 prior to the ADCC/ADCP assay inhibited
IgE-mediated tumour cell killing significantly.
4.2.5 Discussion
Network biology is important to gain an insight into biological responses (Sharan
et al. [2005]). Here, known protein-protein interactions from public databases
were integrated with gene expression profiles gathered from a humanised mice
models in melanoma. Combining information from changes in gene expression
with topological criteria from the analysis of interaction networks, the effects and
the functional roles of immunoglobulin antibody classes were investigated against
cancer cells.
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Figure 4.6: Clustering of Protein-Protein Interaction IgE network. (A) IgE specific
protein-protein interaction network separated into modules (colored spots). Different
color describe different module. Six of the largest modules are visualised. (B) Modules
related to Fc receptor pathway and other immune-related functions. Red spots corre-
spond to over-expressed genes while green spots correspond to under-expressed ones.
Diamond shaped spots are involved in the first module while circle shaped spots consist
the second module.
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Figure 4.7: Inhibition of PTK2 in monocytes reduces their potential to induce anti-
body depended cytotoxicity. Tumor cells killing mediated by IgE was inhibited by the
specific PTK2 kinase inhibitor PF-431396, indicating the relevance of this kinase in the
downstream signaling of IgE.
The superiority of IgE compared to IgG was computationally validated ac-
cording to the graph topological properties and subtle differences in the architec-
ture of the networks. A topological and functional analysis of IgE network was
followed and the observations indicate interesting functional modules, biomark-
ers and novel relationships of proteins whose gene expression is impaired in the
experiments. In order to further confirm the relevance of putative targets and
molecular interactions found by the network analysis further experimental vali-
dation is performing at Guy’s Hospital - St. Jonh’s Institute, with in vivo and in
vitro models to study their underlying biological function.
4.3 Gene Network inference through Correla-
tion based Feature Selection (NetCFS)
The inference of gene interactions from biochemical experiments is a crucial prob-
lem in the post-genomic era that received much attention especially in the field of
79
4. Network Biology of Complex Diseases
network medicine and translational bioinformatics (Marbach et al. [2010]). Sev-
eral computational techniques, such as machine learning approaches, have been
widely used to generate gene expression networks (Lee & Tzou [2009], Marbach
et al. [2010]). Models based on statistical analysis, such as correlation coefficient
and mutual information, were used successfully for the inference of gene regu-
latory networks (Butte et al. [2000], Eisen et al. [1998]). Similarly, supervised
classification approaches have been used to reconstruct gene networks in func-
tional genomics. Decision trees have been employed to predict changes in the
expression of a gene based on the changes in the expression of the other genes
(Soinov et al. [2003]). More recently, Random Forest (RF) was used to construct
regulatory gene networks (Huynh-Thu et al. [2010]). The basic idea is to pick a
gene as a predictor, and build a random forest classifier for that gene, using the
remaining features. Feature selection from the Random Forest returns a rank-
ing for all the genes according to how informative they are to the predictor, as
discussed in Chapter 2. This process is repeated for every gene to determine
subset of genes whose expression is predictive of the target gene. The main chal-
lenge with this approach is that feature selection returns a ranked list of genes,
requiring a threshold for choosing the best subset of features. Therefore, the prob-
lem of choosing an optimal confidence threshold induces bias in this approach.
An implementation of this algorithm, named GENIE3, using the programming
languages R and Matlab has been reported.
The objective is to find a way of solving this threshold problem, using a
similar concept as GENIE3 to generate gene expression networks. The method
can contribute to this endeavor by using Correlation based Feature Selection
(CFS) technique to induce the target features used to decompose the problem
into g different regression problems. In that way, the solution will discard the
threshold constraint and exploit a subset of features chosen by the algorithm.
The principle idea of our method is based on the identification of g correlated
features to generate g sub-problems. In the next section, we will introduce a novel
inference algorithm, NetCFS, with its components. Also, an application will be
described to present the mechanisms of the algorithm.
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4.3.1 NetCFS algorithm
In Chapter 3 was demonstrated the importance of CFS algorithm to extract
subset of genes that are uncorrelated with each other but highly correlated with
the class. CFS works perfectly with numeric classes and is simple by producing
the results relatively quickly, compared to other feature selection techniques. Ac-
cording to the evaluation tables in Chapter 3, CFS subset evaluator returned
satisfactory results for all types of datasets, particularly for the Binary Class
dataset, revealing the power of the algorithm. Comparing the features chosen
by the CFS algorithm with those generated by other feature selection techniques
shows that lot of the features in the CFS subset were also found on the top
ranked genes from other methods. These results are consistent with CFS not
picking random features, and the results obtained are similar to other feature
selection techniques, as shown in Chapter 2. Therefore, in NetCFS algorithm
were used gene sets generated by CFS algorithm.
The main steps of NetCFS algorithm are the following:
1. Gene expression datasets (microarrays) are used as input, genes as variables
and samples as observations.
2. CFS is applied and a gene subset that best differentiates the classes is selected
(as described in Chapter 2)
3. From the selected gene subset (step 2), CFS is re-applied using each gene as
predictor and picking a new subset of genes whose expression is predictive of the
expression of the target gene.
4. GENIE3 and the random forest algorithm are used then to generate an M×M
matrix consisting of a ranking between the target genes and its predictors.
For the implementation of the algorithm, matlab version of GENIE3 is used as
well WEKA API and java classes. To implement statistics and display networks,
the Cytoscape software was used (Shannon et al. [2003]).
Figure 4.8 shows a schematic representation of the NetCFS algorithm to
generate gene expression networks and network statistics. The gene expression
matrix is converted to ARFF format to be read by WEKA application and a
WEKA object is generated. This object is passed to the “Generate Matrix”
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Figure 4.8: Schematic representation of NetCFS software application (more details
of the functions are presented in Appendix B).
process that runs CFS for every gene in the dataset (details about the functions
of “Generate Matrix”, as well of the java implementation of NetCFS, are given in
Appendix B). The result of this process is an M×M matrix where M represents
the number of genes. To generate the weight of the edges, GENIE3 or random
jungle and the resulting weights are used with the network generated from the
CFS to produce the final network. The process “Generate Network” creates a
CSV file containing edges between target node to source node and their weights.
The application also contains a number of features that will be used to test the
networks generated, including generation of random networks and co-expression
networks derived from Pearson Correlation Coefficient.
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4.3.2 Application in Leukemia Dataset
Leukemia dataset described in Chapter 3 was used to infer networks using Pear-
son Correlation Coefficient (PCC) and NetCFS. Co-expression networks were con-
structed for both classes (ALL and AML) by applying cut-off value greater than
0.6 PCC, which is shown previously that generates biologically relevant networks
(Elo et al. [2007], Prieto et al. [2008]). NetCFS was implemented in both classes to
generate directed and undirected networks. To evaluate the statistical significance
and stability of the networks derived from the two methods, random networks
were also generated by applying 100 permutation in the expression dataset. The
simulation showed that on average, nodes in the random networks exhibit low
number of connections (low degree nodes) proving the statistical significance of
the high connected nodes found from NetCFS and PCC.
Random networks follow a Poison distribution while networks derived from
PCC and NetCFS obey to a power law distribution, indicating that these net-
works are scale free. These findings are supported by the statistics in Table
4.3. AML class was tested and networks derived from NetCFS (undirected) and
PCC were highly structured with high connectivity (average degree range: 9.3
to 54.5) and low clustering coefficient (range: 0.03 to 0.4). Note here, that the
degree distribution from NetCFS is very low compared to the networks derived
from PCC, which adhere to the properties of small-world networks with only few
highly-connected genes, and most genes having only a low number of interaction
partners
A small-world network has a small diameter and a large clustering coefficient
(see section 4.1), which is believed to be related to an efficient and controlled flow
of information
Table 4.3: Topological parameters of networks derived from NetCFS and PCC
Network Average Diameter Clustering
Degree Coefficient
AML (undirected) 9.356 9 0.041
AML PCC 0.7 54.526 6 0.036
AML PCC 0.8 27.587 9 0.32
AML PCC 0.9 15.634 11 0.45
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The networks were compared on the basis of the hub genes generated. Hubs
were defined as nodes with a degree of 75 or greater and they obtained by the
CFS algorithm for ALL and AML networks. These genes were compared to the
same genes found in the respective Co-expression Networks (created with different
cutoffs). Table 4.4 shows the result for class AML.
Table 4.4: Hub genes according to the number of their neighbors
Gene Name CFS PCC PCC PCC PCC
0.6 0.7 0.8 0.9
KIAA0001/P2RY14 78 423 231 136 92
Small GTP-binding protein, S10 108 127 32 4 0
IgG Fc binding protein 76 109 27 3 1
KIAA0237 gene 119 112 25 6 1
Glucocorticoid Receptor, Beta 103 274 150 97 1
Centrin mRNA 85 293 104 24 2
Adenylosuccinate synthetase mRNA 77 165 45 7 0
Rho GDP-dissociation Inhibitor 1 116 181 57 6 0
TFE3 transcription factor gene 75 212 84 15 0
TIM17 preprotein translocase 137 85 18 3 0
TNR Tenascin R 92 98 26 3 1
Spermine synthase 116 167 57 11 0
E2F5 E2F transcription factor 5, p130-binding 92 129 48 6 1
Thymopoietin (TMPO) gene 79 111 40 8 0
Polyadenylate binding protein II 92 211 75 14 0
The results presented here are preliminary for the NetCFS algorithm and
focus on the hub genes generated by the two methods. As shown in Table 4.4,
NetCFS exhibit core genes significant for the phenotype of interest that were
not detected (as hubs) by stringent thresholds of Pearson Correlation Coefficient
(PCC). Interestingly, NetCFS identified hub genes that could not be discovered
with stringent PCC thresholds. For instance, targeting IgG Fc binding protein
was found to be an alternative strategy to gene therapy on human acute myeloid
leukemia (AML) blasts by enhancing their immunogenicity for autologous T cells
(Notter et al. [2001]). Similarly, P2RY14, belongs to the family of G-protein
coupled receptors and has a transcript variant (CB2) which has been previously
found to be involved in certain cases of human AML (Jorda et al. [2003]). These
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observations indicate the potential significance of NetCFS as a tool to identify
interesting candidate genes for further study.
4.3.3 Discussion
In this section, a novel algorithm, NetCFS, is introduced and implemented as a
JAVA and Matlab application to infer gene expression networks. This algorithm
is based on GENIE3 where instead of feature selection using random forest a
subset generator named Correlation Feature Selection (CFS) is used. Comparing
to networks derived from Pearson Correlation Coefficient (PCC), it is clear that
NetCFS produce weighted networks. Exploiting the classification algorithm, CFS,
the algorithm reflects the underlying causal interactions among the genes since
a link is displaying the influence of the target gene by the expression of another
gene. Furthermore, using CFS, the algorithm refrained from the problem of
thresholding.
Overall, leukemia application was a benchmark set for testing the algorithm
which is still in first stages. Future research in causality and clustering of the
gene networks that are generated from NetCFS should be applied.
4.3.4 Disclaimer
The experiments and data acquisition for melanoma samples were done by Dr.
Karagiannis Panagiotis. Analysis of data and network construction were done
by myself. I was the sole contributor for the design of NetCFS method and the
algorithm was developed in collaboration with Mr Clint Mizzi
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Chapter 5
Data Mining in Patient
Stratification
This chapter presents an integration of supervised and unsupervised learning
as a way forward to stratified medicine. Not all patients respond similarly to
different treatments. Progress in the understanding of disease mechanisms and
drug actions are opening opportunities to match therapies to patient populations
and therefore may deliver novel approaches in personalised patient medical care.
Section 5.1, gives an overview of the potential biological relevance of us-
ing ensemble decision tree predictors to determine molecular disease subtypes, in
what may initially appear to be a homogenous clinical group. With the compu-
tational pipeline presented here, we can achieve classification of transcriptional
patterns into appropriate sub-groups that can lead to significant insights into dis-
ease mechanisms and novel, targeted therapeutic approaches (sections 5.2 and
5.3).
5.1 Disease Molecular Sub-Types Through En-
semble Decision Trees (EDTs)
Psoriasis is one of the most prevalent chronic inflammatory disorders. It is caused
by an interplay of genetic factors and the environment on the background of
dysregulated immune system (Nestle et al. [2009]). The disease affects 2 - 3
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% of the population worldwide (Lebwohl [2003]) and has variable morphology,
severity and distribution. There are several clinical variants of psoriasis, but the
most common variant, plaque psoriasis, is characterised by chronic, symmetrical,
silvery-scaled, sharply circumscribed plaques (Nestle et al. [2009], Lowes et al.
[2007]). Plaque psoriasis is the most common form of the disease and can begin
in childhood and late adolescence (Type 1) or in adulthood (Type 2), with a
predilection for elbows, knees and the scalp.
Although the cause of psoriasis remains unknown, it is thought to be a com-
plex and multifactorial disorder brought about by the combination of multiple
susceptibility genes (Capon et al. [2007], Liu et al. [2008], Zhang et al. [2009]),
a dysregulated immune system (Volpe et al. [2008]) and environmental factors
(Krueger [2002]). Through Genome Wide Association Studies (GWAS) (Feng
et al. [2009], Strange et al. [2010]), a number of genetic variants have been iden-
tified as contributing towards psoriasis pathogenesis. A unifying model that in-
tegrates genetic, environmental and immunological aspects of skin inflammation
has been proposed (Valeyev et al. [2010]).
In recent years, progress has been made in understanding the pathogenesis
and treatment of psoriasis. Pathogenesis is mainly linked to activation of several
types of leukocytes that control cellular immunity and to a T-cell-dependent in-
flammatory process in skin that accelerates the growth of epidermal and vascular
cells in psoriasis lesions. More details about the role of cytokines and different
cell-types in psoriasis pathogenesis are given in Chapter 6, section 6.1. Cur-
rent therapeutic approaches against the disease take advantage of proteins or
antibodies aiming either at specific inflammatory co-activators or more generally
at immune cells (Lowes et al. [2007]). While there is now increasing insight into
the genes conferring disease susceptibility, much less is known about the types of
regulatory networks of expressed genes which define the molecular signature of
the disease.
The first large-scale and detailed gene expression studies of psoriasis identi-
fied various differentially expressed genes by comparing non-lesional and lesional
skin against normal tissue (Bowcock et al. [2001], Oestreicher et al. [2001], Zhou
et al. [2003], Haider et al. [2006]). Recent studies have attempted to elucidate the
molecular pathways underlying in psoriasis (Gudjonsson et al. [2009a], Gudjons-
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son et al. [2009b], Gudjonsson et al. [2010],Suarez-Farinas et al. [2010]). However,
determining genes that contribute to complex human disorders through analysis
of microarray data is challenging due to the large number of gene predictors,
their possible interactions, and the small number of samples. Termed the “small
n, large p” problem (Strobl et al. [2007]), this implies that classical statistical
methods cannot be implemented directly in functional genomics approaches for
the identification of diagnostic or prognostic biomarkers. In this respect, deci-
sion trees have proven to be a sensible non-parametric method for classification
and variable selection (Breiman et al. [1984]). Random forest (RF) classifica-
tion is an ensemble of CART decision trees and has been found to outperform
other machine learning techniques for analysis of microarray data (Diaz-Uriarte
& Alvarez de Andres [2006], McKinney et al. [2006], Heidema et al. [2006]), as
discussed in Chapter 2.
In this part of the thesis, a computational methodology based on decision tree
predictors is developed to discover molecular sub-groups from gene expression
data and illustrate gene signatures associated with each group. The random
forest (RF) algorithm (Breiman et al. [1984]) is used here to (i) cluster psoriasis
transcripts into subgroups and (ii) discriminate between disease phenotypes by
generating gene signatures that best differentiate them. RF has been shown to be
robust in noisy data, to avoid over-fitting in cases where the number of features
is larger than the number of observations and to be particularly suitable for the
feature selection process (Diaz-Uriarte & Alvarez de Andres [2006], Jiang et al.
[2009], Hastie et al. [2009]).
More specific to the current analysis, first gene expression profiles in normal
and disease skin tissues were analysed, so as to define common differentially
expressed genes. This core gene set was then used to group psoriatic tissue
samples through RF clustering of real and synthetic data. This step resulted
in dividing psoriatic tissues into two subgroups according to similarity of gene
expression patterns. Finally, RF classification was used to derive gene signatures
able to discriminate between normal and disease phenotypes, including the above-
proposed new psoriatic subgroups. Such gene signatures are discussed in following
sections with respect to their effect on defining distinct molecular characteristics
and were validated through comparisons with other psoriasis gene expression
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studies.
Molecular profiling of psoriatic phenotypes followed by classification of tissue
samples into appropriate disease classes has the potential to derive clusters of
similar transcription responses from the entire repertoire of profiles generated.
Especially in the case of a homogeneous clinical patient group, such as plaque-
type psoriasis, the classification of transcriptional patterns into appropriate sub-
groups may reveal distinct molecular mechanisms that may operate within this
group and may explain variability in response and options of disease treatment.
Overall, given the predictive nature of the decision model employed, such patient
categorisations can lead to significant insights into disease mechanisms and novel,
targeted therapeutic approaches.
5.2 Materials and Methods
5.2.1 Data sources
Microarray data on psoriatic gene expression were obtained from the Genetic As-
sociation Information Network (GAIN) Database (Nair et al. [2009]), available
through the NCBI database of Genotypes and Phenotypes (dbGaP). These ex-
periments describe tissue samples from 71 individuals, of which 34 were healthy
controls (NN) and 37 patients affected by chronic plaque psoriasis. Paired sam-
ples from lesional (PP) and non-lesional (PN) tissues were extracted and gene
expression was measured by microarray experiments on the Affymetrix HU133
Plus 2.0 platform. Raw data were normalized using quantile normalization and
expression estimates were computed using the Robust Multichip Average (RMA)
method (Irizarry et al. [2003]).
Analyses performed on the above dataset were validated through comparison
with gene expression datasets GSE14905 and GSE13355 from the ArrayExpress
database (Parkinson et al. [2011]). The first study consisted of 21 biopsies from
healthy donors and 26 paired non-lesional and lesional plaque type psoriatic pa-
tients (Yao et al. [2008]) and the second dataset comprised 64 normal samples
and 58 psoriatic tissues (Gudjonsson et al. [2010]). Both studies were conducted
on HGU133plus2 Affymetrix chips.
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5.2.2 Differential Expression Analysis
In order to define a core dataset of differentially expressed genes in the psoriatic
phenotypes examined, pairwise comparisons between 34 normal (NN) and 37
lesional (PP) and non-lesional (PN) gene expression vectors were performed. The
differential expression between pairs of samples (PP vs. NN, PN vs. NN, PP vs.
PN) was assessed using GenePattern (Reich et al. [2006]). Significance scores were
assigned to each probe (p-value <0.05), multiple hypothesis testing was applied
with FDR<0.05 to reduce the false positives and the top ranked 5000 probes
were extracted for each pair of samples. Of those, the set with the most common
expression alteration among the three pairwise comparisons was selected. Probes
that mapped to the same gene were averaged and the average intensity across
all corresponding genes was used. A core set of 228 probes common to all three
pairwise comparisons was established. Of these, a total number of 206 unique
known genes were derived yielding 130 up-regulated and 76 down-regulated genes.
Hierarchical clustering and principal component analysis (PCA) were imple-
mented to identify distinct patterns of gene expression within the “core” 206
differentially expressed genes. The PCA procedure was implemented as part of
the PCA package in R1. Hierarchical clustering heat-maps were generated in R
based on Euclidean distance. Z − scores were calculated from the level of nor-
malized expressions of 206 genes according to the mean and standard deviation
of a reference set (control samples, NN).
PCA and Hierarchical clustering were used to confirm the separation of the
three skin-types and then Random Forest was used in an unsupervised way to
identify sub-types/sub-groups within the same skin type, e.g. psoriasis cases.
5.2.3 Decision Tree Classification Model
An ensemble of decision trees model was built according to the random forest
(RF) classifier using a deterministic algorithm (Classification and Regression Tree
Algorithm, CART) (Breiman et al. [1984]). Given a gene expression matrix, a RF
classifier was constructed to classify tissue samples into relevant disease classes
(NN, PN, PP) based on gene expression measurements (variables). Details on
1www.r-project.org
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the classification strategy of RF are given in Chapter 2. Variable importance
measures were implemented through mean decrease in accuracy and the gini
index (GI) (Diaz-Uriarte & Alvarez de Andres [2006]), to find the genes that best
discriminate between the different disease phenotypes. Both measures were tested
and were found to correlate well. The gini index was therefore adopted to express
the relative effects of gene predictors in determining the relevant disease classes
(see Chapter 2). To estimate the empirical p-value for GI, 1000 permutations of
the tissue samples were implemented and the importance values were recalculated
for the permuted data set. The maximum Gini Index over all the genes in every
permutation was recorded and thereby an empirical distribution of the maximum
importance was estimated, as in similar analyses (McDonough et al. [2009], Sohn
et al. [2009]).
5.2.4 Clusters of Disease Sample sub-groups through En-
semble Of Decision Trees (EDTs) classification
A procedure to generate sub-groups of disease samples from gene expression mea-
surements through the use of RF is described here. The random forest proximity
measure, defined through the number of times each tree detects these samples
in the same terminal node, is used as a means to express the similarity between
psoriatic samples from gene expression observations (see Chapter 2). Synthetic
data are generated by randomly sampling from the empirical marginal distri-
butions of variables. RF classification is applied to distinguish the 37 psoriatic
samples from the synthetic data and the dissimilarity matrix is used to indicate
distances between psoriatic samples, as previously (Shi et al. [2005]). Through
multi-dimensional scaling, samples are represented as points before clustering
through CLARA (Kaufman & Rousseeuw [1990]). This procedure was imple-
mented in R. The sub-groups were further tested to assess their differences for
various clinical outcomes (soriasis Area and Severity Index (PASI), Body Mass
index (BMI), Age of Onset, Age and Body Surface Area (BSA)). The statistical
significance of disease clusters with respect to clinical variables was done through
Wilcoxon signed-rank test.
91
5. Data Mining in Patient Stratification
5.2.5 Methods applied for Network and Functional En-
richment Analysis
As discussed in Chapter 4, network representation of a disease phenotype can
give a better insight of the molecular mechanism of the disease. Pairwise Pear-
sons correlation coefficient is estimated for the 206 differentially expressed genes
that were common in all tissues. A similarity matrix was calculated for each
skin sub-type and a co-expression network was visualised using the Cytoscape
software. Markov Cluster Algorithm (MCL) was used to generate the interact-
ing groups (clusters) via genes sharing higher-order connectivity in their local
neighborhoods (Enright et al. [2002]). To assess statistically significant enriched
pathways involved in the four different skin groups, p-values were calculated us-
ing the hypergeometric statistical test and False Discovery Rate (FDR<0.05) was
used to correct for multiple comparisons. The default background distribution is
considered to be the whole genome. Pathway enrichment analysis was performed
using the ReactomePA package in Bioconductor (Yu et al. [2012]).
5.3 Pipeline for patient stratification
A pipeline (Figure 5.1) for patient stratification according to gene expression
profiles in psoriasis was implemented to generate molecular sub-groups and un-
cover gene signatures associated with each disease group. Such an approach has
possible predictive implications: given relevant expression measurements for key
signature genes, uncharacterised tissue samples can be ascribed to these prede-
fined disease classes, which can reflect different disease prognosis or response to
treatment.
5.3.1 Gene expression patterns define a core set of dys-
regulated genes among normal, non-lesional and le-
sional skin
Skin samples from psoriatic patients were either of inflamed, lesional type (PP,
involved skin) or non-inflamed, non-lesional tissue (PN, uninvolved skin). These
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Figure 5.1: Pipeline for patient stratification
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were analysed together with skin samples from normal individuals (denoted as
NN). Differential expression analysis was performed and involved three pairwise
comparisons between tissue datasets (i.e. NN vs. PN, PN vs. PP and NN vs.
PP), resulting in three sets of differentially expressed probe sets per pair (p-
value< 0.05 and FDR<0.05). A set of 228 probes was shared across all datasets
(Figures 5.1 and 5.2a) that corresponded to a total number of 206 unique genes,
of which 130 genes were over-expressed and 76 under-expressed in PP samples
compared to NN. This group of genes constituted a core set of genes expressed
differentially across the three disease phenotypes and was used to derive disease-
specific expression patterns in the RF-based procedure described in the following
sections.
Unsupervised hierarchical clustering was carried out on the set of 206 core
genes to explore and visualise the patterns of gene expression from normal (NN)
to non-lesional (PN) and then to lesional (PP) skin samples. Figure 5.2b shows
an overview of gene expression for the core probe sets, clustered according to sim-
ilarity of expression across NN, PN and PP samples. This visualisation represents
a striking outline of the varying transcriptional patterns at each disease phase,
progressing gradually from generally non-differentiated gene expression in non-
inflamed tissues (NN, PN), to markedly differentiated genes in lesional samples
(PP).
Principal component analysis (PCA) was used to assess the clustering of sam-
ples when progressing from un-inflamed to inflamed skin. There was a clear dis-
tinction between lesional (PP) and non-lesional (NN and PN) phenotypes (Fig-
ure 5.2c), manifested as distinct clusters of samples from normal to the involved
phenotype through non-involved skin. Normal and psoriatic un-involved samples
(NN and PN) co-clustered away from involved cases (PP), in agreement with pre-
viously published analyses (Gudjonsson et al. [2009b], Zhou et al. [2003]). This
demonstrated the changes in gene expression profiles across NN, PN and PP skin
and revealed a marked difference between inflamed (PP) skin and un-inflamed
(PN and NN) phenotypes.
Among the strongly dysregulated genes in the core gene set, several of the
under-expressed genes were found to encode proteins involved in fibrotic processes
and immune responses. For example, FN1, PDGFC, MYH10 are involved in the
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Figure 5.2: (A) Gene expression was analysed to reveal probe sets that were differen-
tially expressed between pairwise comparisons of PP, PN and NN tissue groups. The
Venn diagram shows the number of probe sets identified in each of the three differential
analyses performed. Probe sets common to all three pairwise comparisons were 228 (206
genes). (B) Microarray analysis of 108 skin tissue samples (in columns) for 206 genes
(in rows) common to all tissue types, identified through differential expression analysis.
Tissues have been grouped according to disease phenotype (normal NN, non-lesional
PN and lesional PP) and heatmap colours indicate z-score of each gene expression value
against the mean of corresponding normal values, (green: decreased expression, red:
increased expression, inset). Similarity of gene expression vectors across all samples is
represented by the dendrogram on the left. (C) Principal Component Analysis to sug-
gest sample clustering across skin types according to gene expression patterns. Good
separation of inflamed (PP) and non-inflamed (PN, NN) tissues was observed, indi-
cating a progression from normal (red) to lesional skin (blue) through the non-lesional
cases (green)
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regulation of the actin cytoskeleton, which participates in fundamental processes
such as the regulation of cell shape, motility and adhesion [30]. DIXDC1, CGNL1
and SSPN encode cell adhesion and junction proteins. Betacellulin (BTC), IL1F7,
CD81, FN1, PDGFC and SCARB2 are immune response genes. In addition,
MEGF9, BTC, FN1, PHF2 belong to the family of growth factors that acti-
vate the epidermal growth factor receptor,EGFR (ErbB1) and according to a
previous study BTC plays an important role in skin morphogenesis (Schneider
et al. [2008]). Among the over-expressed genes, several participate in keratinocyte
proliferation and differentiation (EREG, KLK8 and PPARD). Of note is KLK8,
potentially involved in the modulation of hyperkeratosis in a psoriatic lesion and
may be implicated in preventing excessive keratinocyte proliferation, resulting in
increased shedding of corneocytes. This is clinically reflected in the copious quan-
tities of scale that are shed by psoriasis patients (Kishibe et al. [2007]). Genes
LTB4R2 and PPARD are also involved in keratinocyte migration. Finally, a group
of up-regulated genes SNRPG, SNRPD1, SNRPD3, SNRPA1, SNRPC, SF3B14,
SFRS9 is involved in spliceosomal assembly. Overall, most dys-regulated genes
were found to be consistent with current knowledge.
5.3.2 Distinctive gene expression patterns between lesional
and non-lesional tissues (PP vs. PN)
Following the general patterns of psoriatic tissue differentiation, the use of de-
cision tree ensembles was explored to classify samples into PN and PP classes
and derive the major gene patterns able to discriminate the psoriatic phenotypes
(see Figure 5.1, step1). We used 74 tissue samples from psoriasis patients,
each characterised by a vector of core gene expression values, and a random for-
est (RF) classifier (Breiman et al. [1984]) was applied to distinguish samples in
lesional (PP) and non-lesional (PN) phenotypes. The classifier employed 1000
trees with training of each tree performed on 2
3
of samples and testing on the
remaining 1
3
. The prediction accuracy of the classifier was high (accuracy 97.3 %,
OOB error rate 2.7 %).
The random forest classifier was then used to indicate the relevant importance
of features in the classification, i.e. which genes are more important in predicting
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Figure 5.3: Informative genes for the classification of skin samples in lesional and
non-lesional classes (PP and PN, respectively). Gini index (GI) was used to generate
a variable importance measure and provide an estimate of feature (gene) relevance to
disease state. The five most important genes in determining disease classes were IL1F7,
C7orf59, AQP9, BTC and TUFT1
the appropriate disease class. Genes were ranked through the gini index (GI) in
terms of their discriminative power (see Methods) and Figure 5.3 shows genes
with the highest GI when distinguishing inflamed (PP) from non-inflamed (PN)
skin. Five genes indicated through this procedure were IL1F7, C7orf59, AQP9,
BTC and TUFT1 and were all related to immune response processes.
5.3.3 Identification of molecular sub-types within psori-
atic tissue samples
In addition to key patterns that defined disease outcome in psoriatic tissues above,
we used random forest in unsupervised mode, as a clustering platform to group
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lesional psoriasis samples based on their gene expression properties (see Fig-
ure 5.1, step 2). The aim was to generate two sub-groups among disease tissues
(PP), before further classification runs could identify molecular differences among
them (Figure 5.1, step 3, discussed later). First synthetic data were generated
by randomly sampling the gene expression observations. Then, a random for-
est predictor was built to distinguish the real from synthetic data and define a
similarity measure between the psoriatic cases in the form of the random forest
proximity measure. Finally, CLARA clustering of the proximity matrix parti-
tioned the psoriatic cases into two groups, named PP01 and PP02 (Figure 5.1,
step 2). The adjusted rand index to indicate the difference between the two
identified sub-groups was -0.0269.
The relationship between these sub-groups and clinically measurable parame-
ters, were assessed. Psoriasis Area and Severity Index (PASI), Body Mass index
(BMI), Age of Onset, Age and Body Surface Area (BSA) were evaluated against
subgroups PP01 and PP02. Of these, age was found to be significantly altered
between the two subgroups (p-value 0.0184, Wilcoxon signed-rank test). It is
emphasised here that plaque-type psoriasis constitutes a homogeneous clinical
group, distinct from other forms of psoriasis. Therefore, it is not surprising that
such coarse-grained clinical parameters can not capture the subtle differences in
gene expression profiles in plaque psoriasis sub-groups (PP01, PP02). Instead,
the focus here is to distinguish the underlying biological mechanisms, in terms
of distinct biochemical pathways and interactions that act in these subgroups, as
we report in following sections.
Having separated psoriatic samples into two sub-groups, a new gene expression
matrix, where PP samples were split into PP01 and PP02, was used as input to
another round of RF classification (see Figure 5.1, step 3). The core genes (total
of 206) were used as variables to classify 108 samples in any of the four classes
(normal NN, non-lesional PN, first lesional group PP01, or second lesional group
PP02). The purpose of this series of experiments was to assess the discriminatory
power of different genes in deriving the four disease classes through classification.
The classifier showed good prediction accuracy (79.6 %, OOB error rate 20.37 %,
1000 trees). Figure 5.4 shows the MDS plot for this classification experiment,
illustrating the relative clustering of samples in four skin phenotypes. As before,
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Figure 5.4: A multidimensional scaling (MDS) plot to illustrate the molecular group-
ing of samples. A dissimilarity matrix in random forest is constructed through the use
of synthetic data drawn from the distribution of psoriatic samples (see Methods). Pa-
tients are clustered according to these dissimilarities and two distinct psoriatic groups
are identified, PP01 (green) and PP02 (purple). All lesional samples (PP) cluster
away from both normal (NN) and non-lesional (PN) tissue samples, in accordance to
observations in figure 5.2c
non-inflamed tissues (NN and PN) clustered away from the inflamed tissues (PP).
Additionally, the relative segregation of the two PP subgroups was also apparent.
The contribution of particular genes in differentiating the corresponding dis-
ease phenotypes was also assessed through gini index as variable importance
measure and Figure 5.5 illustrates a measure of the predictive power of genes
in classification. This set of most informative genes in Figure 5.5 were also
confirmed by calculating the empirical p-value by permutating the tissue labels
Wang et al. [2010].
To extract the differences in gene expression between the two psoriasis sub-
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Figure 5.5: Genes identified as most informative through RF classification of skin
tissues in four molecular groups (NN, PN, PP01 and PP02). Gini index (GI) was used
as variable importance measure for estimating the discriminative power of relevant
features (genes) and, consequently, their relevance to disease state. The five most
important genes in determining disease classes were BTC, CNFN, C20orf11, BUB3
and IL1F7
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Figure 5.6: Markov Cluster Algorithm (MCL) applied on the psoriatic sub-group
tissue sample networks to extract clusters of gene expression. Both networks consisted
of 36 clusters and the largest clusters (number of nodes>8) for both networks are shown
and denoted by colour. Pathway enrichment for these clusters is shown in Tables 6.1
and 6.2 for PP01 and PP02 networks respectively.
groups, a co-expression network was generated of the core genes for each of these
groups (Figure 5.6). This resulted in two networks for PP01 and PP02 with
different topological properties. The PP01 network consisted of 122 nodes with
142 edges, whilst PP02 had 173 nodes with 472 edges. After clustering with MCL,
36 clusters were identified for each patient group, PP01 and PP02, and functional
enrichment analysis of the largest clusters has indicated different biochemical
pathways linked to each of these groups. The PP01 network clusters were enriched
in signalling pathways, such as Wnt Signaling pathway, Notch, TGF-beta, ErbB
and mTOR signalling pathways, whereas clusters in PP02 network were more
involved in metabolic pathways (Tables 1 and 2). This indicated that the two
lesional psoriatic sub-groups possess different functional properties, suggesting
different underlying biological processes.
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5.3.4 Key genes associated with disease sub-classes and
comparison with other studies
Variable importance analysis was used to derive highly discriminative genes in
classification of disease sub-types. As described previously, the gini index (GI),
calculated from RF classification (108 samples, 206 genes, 4 classes, see Figure
5.1, Step 3), was used to rank each of the 206 genes in terms of their discrim-
inatory effect in assigning samples in each of the four tissue groups (NN, PN,
PP01, PP02). The 43 genes with highest GI were schematically represented in a
circular layout (Figure 5.7) to show their effect in each of the four classes. For
example, BTC, part of the ErbB and ERK Signaling pathways, has GI equal to
0.11 for samples classified in the PP01 class and a significantly lower GI when
classifying samples in the other tissue groups (GI=0.041 for NN, GI=0.056 for
PN and GI=0.055 for PP02). Similarly, the importance of the other 43 genes in
classifying samples in the four phenotype classes was determined and is illustrated
(Figure 5.7).
In the NN group, CNFN and BUB3 were more frequently selected to define a
split in the classification trees of the forest, whereas BTC, IL1F7 and TMEM99
(GI>0.02) were important in classification of PN samples. Within the PP group,
BTC, C20orf11, EEF1A1, CNFN, IL1F7, PRSS1/TRY6, SSPN and UCHL3
showed high discriminative value for identifying the PP01 sub-group, whereas
BTC, CNFN, IL1F7, KLK8/KLK9 and TXNDC4 exhibited high importance for
the PP02 sub-group. To further support linking these genes to psoriasis-related
biological mechanisms, the PubMatrix tool was used to look up the discriminatory
genes in the context of eight terms, includingpsoriasis, NK cells, T cells, immune
response, Wnt signalling pathway, Notch signalling pathway, TGF beta signalling
pathway and ErbB signalling pathway [35]. Out of 43 genes, 24 genes were found
to occur together with these terms in biomedical literature, as seen in Figure
5.8. Interestingly, BTC, which exhibited a high discriminative value when char-
acterising PP01 sub-type, was found to be related with ErbB signalling pathway.
The latter was a highly enriched pathway in this sub-group and indicates a po-
tential therapeutic target. IL1RN also had a high GI for samples classified as
PP01 and was previously found to be highly related with T cell activation and
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Figure 5.7: Graphical representation to illustrate the relation between 43 highly
discriminative genes and disease sub-groups. Contributions shown according to gini
index, calculated from random forest classification. The four skin-types (PP01: light
blue, NN: green, PP02: blue, PN: light green) followed by relevant genes are arranged
clockwise. Skin groups and genes are ordered according to shared pairing links
103
5. Data Mining in Patient Stratification
Figure 5.8: Text mining results for validation process according to the literature.
Co-occurrence of gene names with disease-related terms, such aspsoriasis, NK cells, T
cells, immune response, Wnt signalling pathway, Notch signalling pathway, TGF beta
signalling pathway and ErbB signalling pathway was searched in Pubmed abstracts
through PubMatrix
immune response.
The pipeline outlined above was replicated with two other psoriatic datasets
from (Gudjonsson et al. [2009b])(Gudjonsson dataset) and (Yao et al. [2008])
(Yao dataset). Skin samples were grouped into sub-types according to their gene
expression patterns, as for the GAIN dataset, using similarities derived from the
proximity matrix through random forest algorithm (Figure 5.9). By comparing
across the three datasets and the relevant gene signatures derived, the importance
of specific genes was noted. BTC, CNFN, IL1F7 were important discriminant
genes in the GAIN data, while SNRPC and SMURF2 played a greater role in the
Yao and Gudjonsson datasets. Generating a consistent outcome of gene signa-
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Figure 5.9: A multidimensional scaling plot of psoriasis datasets from (A) Gudjonnson
et al. 2010 and (B) Yao et al. 2008 to illustrate grouping of samples according to
random forest clustering.
tures across all datasets is challenging, as patient cohorts may vary significantly.
Although the Yao data seem difficult to reproduce, considerable similarity ex-
ists between the other two datasets. Specifically, one of the disease subgroups
in these dataset points to pathways related to Notch signalling, ErbB and TGF
beta suggesting that this group may be more amenable to related therapeutic
options.
Note that evaluation of psoriasis transcriptome has been assessed elsewhere
(Suarez-Farinas et al. [2010]) and the observed low reproducibility across various
studies was attributed to wide variability in clinical protocols, platforms and
sample handling among different datasets. It is envisaged that the application
of the present and similar strategies for predictive modelling and stratification
of expression patterns, as well as the availability of larger patient studies will
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bridge the disparities between various studies and yield a sharper picture of gene
contributions to this complex disorder.
5.4 Discussion
Large-scale genome characterisations, through the analysis of gene sequence and
expression data, are gaining increasing interest and have the potential to greatly
improve our understanding of the physiological and molecular mechanisms under-
lying disease pathogenesis and progression. Various models of data stratification
and identification of patient groups through various data mining protocols are
used to support a decision making process in biomedicine. Here the use of ran-
dom forest to partition psoriatic tissues in appropriate disease groups is illustrated
and estimates of relevant gene predictors were generated.
Psoriasis is a common, complex immuno-genetic inflammatory disease of pri-
marily the skin. The underlying genetics of the disease are complex with nu-
merous implicated susceptibility genes, where replication of single loci has been
confirmed for only a handful of these genes. Patients suffering from psoriasis
can exhibit a host of different clinical phenotypes and response to therapy is
varied and unpredictable, even within a similar clinical phenotype, suggesting
underlying transcriptional differences between and within the clinical groups.
The ability to investigate the underlying immuno-genomic components of these
clinical sub-phenotypes has not been a possibility, until now. Identification of
different transcriptional signatures and their associated molecular pathways con-
tribute toward defining a set of biomarkers, which could serve as diagnostic and
therapeutic responder tools. A computational strategy is outlined to identify
molecular sub-types and corresponding putative biomarkers that may be crucial
in the understanding and prediction of disease pathogenesis. Of the 206 common
differentially expressed genes identified between normal, psoriatic lesional and
psoriatic non-lesional groups, 130 genes (63.1%) were up-regulated and 76 genes
(36.9%) were down-regulated. Dysregulated genes discovered in this study were
involved in epidermal cell modulation, cell cycling and immune responses.
Microarray analysis of gene expression has been widely used to differentiate
lesional and non-lesional skin of psoriatic patients (Nomura et al. [2003], Lee
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et al. [2004]). Recently, large-scale analysis using whole genome array platforms
on numerous patients per sample group have been undertaken with the aim of
identifying gene expression profiles associated with a specific psoriatic phenotype
(Liu et al. [2008], Zhang et al. [2009], Feng et al. [2009], Swindell et al. [2012]). In
this chapter, a method is presented for identifying sub-phenotypes of lesional skin
from psoriasis patients based on patterns of gene expression that characterise each
group and differ significantly from normal human skin. This approach is based
on a decision tree analysis of gene expression data, the extraction of associations
among gene expression patterns and the identification of functional annotations
and molecular signatures.
The random forest decision tree model was applied to lesional skin group to
derive patient sub-groups (PP01 and PP02), which are characterised by specific
differentially expressed genes. The PP01 group was defined by the up-regulation
of HLA-E, which is the inhibitory ligand for innate NK cells. HLA-E takes part in
processing and presenting antigen to innate immune cells. The PP02 group had
more up-regulated genes related to the cells of the adaptive immune system such
as CTLA-4 (associated with modulation of T helper responses), IFI30 (involved in
MHC Class II antigen processing), IL4IL (immunomodulatory enzyme produced
by dendritic cells), PTPN2 (associated with autoimmune disorders such as type 1
diabetes mellitus and Crohns disease) and most interestingly SERPINB8, which
has been identified through Genome-Wide Association Studies (GWAS) as a new
psoriasis susceptibility locus in the Chinese population (Sun et al. [2010]).
With regards to mechanistic details of the pathways that operate in psori-
atic sub-groups, the ErbB signalling pathway has been identified for subgroup
PP01 (Table 6.1). This pathway consists of a family of four related receptor
tyrosine kinases (ErbB1-4) which, when activated trigger many different signal
transduction pathways leading to increased proliferation, survival, motility, and
invasiveness. All of these responses are important aspects of wound healing and
psoriasis has many elements in common with wound healing. The main clinical
feature of psoriasis relates to the thickened epidermis as a result of what may
initially have been an epidermal barrier insult. An attempt to restore epidermal
integrity is reflected in the activation of the ErbB signalling pathway. However
in psoriasis it is possible that this pathway, along with other signalling pathways
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is dysregulated (Citri & Yarden [2006]).
Other signalling pathways seem to be in effect in psoriasis sub-group PP02
(Table 6.2), for example signalling by BMP. Bone morphogenetic proteins (BMP)
are members of the transforming growth factor-beta (TGF beta) superfamily and
regulate a large variety of biological responses in different cells and tissues. It has
been reported that BMPs are implicated in a variety of pathobiologic processes in
skin, including wound healing, psoriasis, and carcinogenesis (Botchkarev [2003]).
In our analysis, when several patient clinical variables were compared across
the two classes (PP01 and PP02), age was found to be significantly altered in these
subgroups, indicating that this is an important factor in disease manifestations. It
is worth noting that although the differences in PP01 and PP02 groups are quite
marked on a transcriptional level, yet they are clinically difficult to distinguish.
This observation may help explain why some patients have a different disease
course to others and why some respond better to therapy than others within a
given clinical phenotype. The ability to generate molecular sub-types provides
putative biomarkers, which with further refinement and replication, could prove
to be useful in predicting disease severity, progression and response to therapy in
an individualised manner.
Random forest has become a popular Ensemble of Decision Tree (EDT) tool
for analysing high-throughput genomic data. Due to the large number of vari-
ables associated with characterisation of clinical samples through gene expression
measurements, reduction of dimensionality through feature selection or priori-
tisation is critical in disease property prediction. Through this computational
analysis, there is an emerging picture of important gene predictors in psoriasis,
as well as differentiation of disease in different subgroups. Future work based on
richer datasets that profile larger patient cohorts, with stringent clinical pheno-
typing, will have the potential to draw clearer conclusions about this complex
autoimmune skin disease.
5.5 Disclaimer
I am the sole contributor for the development of the computational pipeline de-
scribed in this chapter.
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Table 5.1: Pathway enrichment in the PP01 psoriatic group
Pathway Name p-value q-value
Cluster 1
NOTCH1 Intracellular Domain Regulates Transcription 0.0008 0.0227
Signaling by NOTCH1 0.0017 0.0254
Signaling by NOTCH 0.0028 0.0275
NOTCH1 Intracellular Domain Regulates Transcription 0.0007 0.0227
Cluster 2
Urea cycle 0.0066 0.0187
Synthesis of very long-chain fatty acyl-CoAs 0.0104 0.0187
Fatty Acyl-CoA Biosynthesis 0.0133 0.0187
Triglyceride Biosynthesis 0.0271 0.0286
Cluster 3
PI3K events in ERBB4 signaling 0.0003 0.0054
PI3K events in ERBB2 signaling 0.0004 0.0054
Signaling by ERBB4 0.0019 0.0142
Signaling by ERBB2 0.0024 0.0142
AKT phosphorylates targets in the nucleus 0.0059 0.0289
Signaling by TGF beta 0.0106 0.0400
SHC1 events in ERBB4 signaling 0.0139 0.0400
GRB2 events in ERBB2 signaling 0.0152 0.0400
Signaling by BMP 0.0159 0.0400
SHC1 events in ERBB2 signaling 0.0165 0.0400
PIP3 activates AKT signaling 0.0205 0.0434
Immune System 0.0215 0.0434
PI3K/AKT activation 0.0263 0.0447
Nuclear signaling by ERBB4 0.0273 0.0447
GAB1 signalosome 0.0283 0.0447
Interleukin-1 signaling 0.0296 0.0447
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Table 5.2: Pathway enrichment in the PP02 psoriatic group
Pathway Name p-value q-value
Cluster 2
Transport of Glycerol from Adipocytes to the Liver by Aquaporins 0.0018 0.0158
Transport by Aquaporins 0.0102 0.0419
Signaling by TGF beta 0.0149 0.0419
Signaling by BMP 0.0223 0.0470
Cluster 3
Respiratory electron transport 0.0012 0.0009
Respiratory electron transport, ATP synthesis by chemiosmotic
coupling, and heat production by uncoupling proteins 0.0018 0.0009
The citric acid (TCA) cycle and respiratory electron transport 0.0036 0.0013
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Chapter 6
Systems Biology For Skin
Inflammation
Systems biology aims to understand the complex biological systems. The com-
plexity of human skin due to the myriad of roles and players that are activated in
different phenotypes increases the need to unravel the genomic, trascriptomic and
proteomic information in the attempt to intelligently translate experimental data
into clinically meaningful parameters and bring the bench closer to the bedside.
In this part of the thesis, topological and functional properties of psoriasis
are presented in association with the deconvolution of cytokine-related path-
ways(section 6.2). Together, a novel systems biology approach is proposed,
combining clinically relevant whole-tissue models with integrative systems anal-
ysis to identify unexpected mechanisms of disease progression and development.
This integrative approach was applied to deconvolute novel IL-22-related gene
sets in psoriatic disease pathogenesis and therapeutic response (section 6.3).
6.1 Psoriasis
In the previous chapter, psoriasis is introduced as a homogeneous clinical phe-
notype and report a computational pipeline for the differentiation of disease in
different subgroups. Here, the environmental and genetic factors that play a role
in the pathogenesis of psoriasis will be introduced.
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Many different components and processes contribute significantly to psoriasis
disease initiation and maintenance (Figure 6.1). In the initiation phase, an un-
known environmental factor induces keratinocytes to produce pro-inflammatory
cytokines namely IL-1, IL-6 and Tumour Necrosis Factor (TNF). Under stress
conditions, fibroblasts and innate immune cells such as the Natural Killer T
(NKT) cells enhance local inflammatory response. Damaged keratinocytes re-
lease self DNA, which activates plasmocytoid dendritic cells (pDCs) leading to
the release of IFN, which in turn activates dermal DCs. These dermal DCs
migrate to the lymph nodes and present poorly characterised antigens to naive
T-cells . Naive T cells usually travel around the body frequently visiting lymph
nodes. Each of these naive T cells does so in the hope of finding a specific peptide
which fits to its unique T cell Receptor (TCR). As a result of this interaction,
naive T-cells proliferate and differentiate into CD4 Th1 (T helper 1) or Th17 (T
helper 17) effector cells. Activated Th1 and Th17 express adhesion molecules
and different chemokine receptors namely CXCR3, CCR4, and CCR6 on their
surface. Due to the chemokines produced by activated keratinocytes, Th1 and
Th17 migrate back to psoriatic dermis. In the inflammed skin, Th1 and Th17
secrete INF, IL-17, and IL-22. Effector cells are short-lived, but some activated
CD4 and CD8 T-cells become memory cells. Cytokines produced by the Th1
and Th17 cells, stimulate keratinocytes to proliferate and produce phagocyte-
recruiting chemokines such as CXCL1, CXCL3, CXCL5, CXCL8. In addition,
activated DCs promote clonal expansion of memory CD4 and CD8 T-cells and
their migration to the skin epidermis. This migration leads to better cross-talk
between cells, and secretion of pro-inflammatory cytokines by CD4 (Th1, Th17)
and CD8 (CTL) T-cells leads to amplification of the inflammatory reaction. As
a result, specific psoriatic lesions occur (Nestle et al. [2009]).
6.2 Molecular Topology of Psoriasis Disease
Psoriatic human skin is a complex biological system (Nestle et al. [2009]) and a
further investigation and characterisation of its genetic architecture might help re-
veal the biological basis of disease associations which modify disease progression,
to ultimately provide insight into the pathogenesis of psoriasis. A systems-based
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Figure 6.1: Immunopathogenesis of psoriasis (Picture adapted from Di Meglio et al.
[2011])
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analysis may be of value in attempting to provide a more comprehensive view
of skin pathology. In recent years, data-driven approaches have been applied
in understanding the pathogenesis and treatment of psoriasis (Gudjonsson et al.
[2009b], Gudjonsson et al. [2010], Suarez-Farinas et al. [2010]). Some studies
have attempted to elucidate the molecular pathways underlying in psoriasis, and
other detailed gene expression studies have identified various differentially ex-
pressed genes by comparing non-lesional and lesional skin against normal tissue
(Yao et al. [2008], Gudjonsson et al. [2010], Suarez-Farinas et al. [2010]). More
recently, genome-wide expression analysis has been implemented to develop a
computational pipeline to characterise heterogeneity among lesional skin samples
(Ainali et al. [2012]), and also to identify inflammatory and cytokine activity phe-
notypes associated with presentation of chronic plaque psoriasis (Swindell et al.
[2012]). Subsequently, initial computational models (Valeyev et al. [2010], Penner
et al. [2012]) have focused on a dynamical systems approach, and have provided
simplified but informative pictures of abhorrent cytokine interactions driving im-
mune system responses characteristic of psoriasis. These modelling approaches
are very useful for understanding general principles of how genetic perturbations
may lead to psoriasis in a qualitative way.
However despite the recent considerable interest, a major challenge in trans-
lational research is the development of robust pipelines to modulate disease in an
individualised and optimised fashion. Systems biology approaches that model bio-
logical systems can represent the complex disease interactions efficiently, and offer
insights into underlying mechanisms and perturbations due to disease (Schadt
& Bjorkegren [2012]). Since microarray-based gene expression data have been
generated widely and contain information about concerted changes in transcript
levels, an integrative network biology multistep procedure is proposed for iden-
tifying potential key drivers of psoriasis. Using gene expression profiles to infer
gene-gene interactions, a gene co-expression network is generated. With graph-
clustering techniques (Newman [2006]), we further identify clusters of genes and
determine cytokine relevance. Because clusters of co-expressed genes are known
to be functionally related (Stuart et al. [2003]), functional enrichment for GO or
KEGG pathway terms is performed. In that way, this analysis not only identifies
known biological processes and pathways involved in psoriasis disease, but also
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offers a better understanding of the molecular basis of this disease phenotype by
establishing cytokine-related key networks of co-expressed genes, as well as their
topological and functional properties.
6.2.1 Materials and Methods
For this study, the dataset described, previously in chapter 5, is used. Briefly, we
used tissue samples from 71 individuals, of which 34 were healthy controls (NN)
and 37 were biopsies from patients affected by chronic plaque psoriasis. Tissues
from both lesional (PP) and non-lesional (PN) areas were taken. Raw data were
normalized using quantile normalization and expression estimates were computed
using the Robust Multichip Average (RMA) method, on the Affymetrix HU133
Plus 2.0 platform (Irizarry et al. [2003]).
Microarray expression profiles for normal human epidermal Keratinocytes
(KCs) treated with IL-20 family cytokines were also extracted from GEO database
(GSE7216) (Sa et al. [2007]). Also, expression profiles for normal human epider-
mal Keratinocytes (KCs) treated with IL-17 were derived (GSE7216). Differential
Expression Analysis was carried out using the MATLAB software and functions
from Bioinformatics Toolbox 1. Genes that were not expressed or had only small
variability across the treated and untreated samples were removed. A t-test was
conducted to identify significant changes for each gene in their expression values
between the different phenotypes so as to extract cytokine-related over and/or
under expressed genes (Dudoit et al. [2003]). Genes with p − value < 0.05 and
foldchange(fch) > 1.5 were considered to be statistically significant.
Gene networks were inferred by using Pearson Correlation Coefficient (PCC),
one of the metrics that were discussed in Chapter 4. Pairwise Pearson Corre-
lation Coefficient (PCC) is estimated across the gene expression profiles and a
similarity matrix was calculated for each of the skin tissue types (NN, PN and
PP). Gene pairs that correlated above a threshold of 0.7 PCC were represented
in the form of a network and a co-expression network was visualised using the
Cytoscape software. Nodes (vertices) corresponded to genes and edges (links)
corresponded to the similarity of the expression of two genes were across different
1http://www.mathworks.co.uk/products/bioinfo/
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samples. Efficiency and stability of the topology of our networks was examined by
rewiring links in the original networks (Maslov & Sneppen [2002]). For functional
enrichment analysis of gene sets, the DAVID 6.7 bioinformatics database (June
2011) 1 was used and genes were matched with Gene Ontology (GO) terms and
KEGG or Reactome pathways. Further to identify cluster structure in our net-
works, we used Markov Cluster Algorithm (MCL) (Enright et al. [2002]), which
is also considered in Chapter 5.
6.2.2 Co-expression Models of Skin-related Phenotypes
Co-expression networks of skin phenotypes, normal, peri-lesional and lesional
tissue samples, were built using all the genes at PCC 0.9, followed by a power
law distribution and R-squared values ranging between 0.7 to 0.95, suggesting
the structure of scale free networks (Figure 6.2). Highly connected nodes, hubs,
indicate the likelihood that a gene is essential and its protein product play a
major role in activation or inhibition of other proteins. Note here, that R-squared
value for peri-lesional phenotype (PP) is larger (R2=0.914) indicating a stronger
linear association between the data variables (genes). The cut-off value of PCC
≥ 0.9 was selected according to recent studies where they have employed similar
threshold criteria and have shown that gene co-expression landscape derived from
PCC over 0.7 were proved to be more biologically relevant (Elo et al. [2007],
Prieto et al. [2008]). In addition, below this cut-off the networks are very large
suggesting the potential existence of many false positive edges (Figure 6.3).
Local topological parameters of the identified networks were further estimated
and presented in Table 6.1. Networks derived from skin phenotypes were highly
structured with high connectivity (average degree range: 6.3 to 49.7) and low
clustering coefficient (range: 0.24 to 0.49). Interestingly, NN network has a large
number of nodes with high connectivity (hubs) whereas networks derived from
the patient tissue samples (PN and PP) have less number of hubs as is inferred
by the average degree values.
However, due to the cytokine environment that sustains the pathogenic cas-
cade of the psoriasis disease, sets of cytokine-responsive transcripts, identified
1http://david.abcc.ncifcrf.gov/
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Figure 6.2: Log-log plots of node degree and frequency distribution for the three skin
phenotypes. The power law distribution suggests that all the networks are scale-free
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Figure 6.3: Association plots of (A) the number of edges/links included in the network
according to the cut-off value of the pearson correlation coefficient (PCC) and (B) the
number of genes .
118
6. Systems Biology For Skin Inflammation
Table 6.1: Topological parameters of co-expression networks derived from the three
skin phenotypes (NN, PN and PP, respectively)
Number Number Average Clustering
Networks of of Diameter
Nodes Edges Degree Coefficient
NN 1664 41359 49.710 9 0.484
PN 1753 7326 8.358 24 0.2763
PP 1416 4461 6.3008 18 0.243
from in vitro experiments performed with cultured keratinocytes, are used to
map onto our networks and identify differences in cytokine activity among the
three skin phenotypes (NN, PN and PP) (Gudjonsson et al. [2004]). Molecu-
lar signatures are established for INFg, IL17, IL19, IL20, IL22, IL24, and IL1b
cytokines and their existence in the different skin phenotypes is demonstrated
(Table 6.2). IL17 is overrepresented in the networks with a high coverage in
PP. IL22 and IL24 exhibit also higher coverage than the other cytokines in the
peri-lesional (PP) network. Also, there is an increase in the presence of the
cytokines from the PN to PP networks, demonstrating the potential induction
of keratinocytes producing pro-inflammatory cytokines. The smallest effect has
IL19. Intriguingly, there is a high coverage of IL10 family cytokines in normal
(NN) network compared to the other skin phenotypes, which could be possibly
explained due to the variability of healthy individuals.
Table 6.2: Presence of cytokines molecular signatures in the skin networks
Networks INFg IL17 IL19 IL20 IL22 IL24 IL1b
NN 1.368% 10.29% 0.64% 1.37% 15.6% 5.99% 2.32%
PN 0.7% 7.94% 0.26% 1.27% 8.33% 2.70% 1.60%
PP 1.07% 10.58% 0.54% 1.35% 6.88% 3.34% 2.48%
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6.2.3 Critical modules in lesional skin exhibit cytokine-
related sub-networks
MCL clustering is further implemented for identifying groups of genes that are
highly connected in the skin networks. The algorithm finds cluster structure
in graphs by estimating the random walks through it and determines clusters
via genes sharing higher-order connectivity in their local neighborhoods (Enright
et al. [2002]). Using the default settings of the algorithm, 194 clusters were found
in the NN network, of which five contained more than 30 genes. Similarly, 419
clusters were found in PN with only three consisting of more than 20 genes and
362 clusters in PP network, of which six contained more than 25 genes. Enrich-
ment of each largest MCL cluster in the PP network was further applied for GO
and pathway terms and identified epidermis development, immune response, ker-
atinocyte differentiation as well TGF signalling, Pi3k/Akt Signaling and other
immune related pathways. We also observed an overrepresentation of IL22 and
IL24 cytokines (blue and red, respectively, in Figure 6.4) in one of the largest
networks that was enriched in epidermis development, which was recently vali-
dated (He & Liang [2010]) (Figure 6.4). IL17, as well, is represented in one of
the largest networks.
Therefore, cytokines activity was identified within the psoriatic network and
the importance of IL22 and IL24 in keratinocyte and epidermis development
was ascertained. The observations highlight the role of cytokine factors in the
prevention and treatment of psoriasis and pinpoint the need for further validation
as therapeutic targets. In the following section, IL22 is applied in different whole
tissue models to uncover its underlying role in the pathogenesis of the disease
and explore the clinical relevance of it in psoriasis. Combining disease relevant
models and integrative network analysis, the in vivo effect of IL-22 is studied
on normal human skin and its kinetics in human psoriasis pathogenesis, and in
disease progression.
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Figure 6.4: Clustering within psoriatic gene coexpression network to identify groups
of genes that are functionally related (step 1). The largest clusters are visualized and
cytokine - gene sets are aggregating within the largest cluster in the network (step 2).
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6.3 Molecular profiling of in vivo models of hu-
man skin reveals IL-22 as a therapeutic tar-
get in the prevention and treatment of pso-
riasis
The discovery of new cytokines as therapeutic targets has great promise, but
limitations abound due to the lack of clinical relevance when translating in vitro
and animal data into the context of human disease (Chapman et al. [2007], Loisel
et al. [2007]). Typically, preclinical models fail to reproduce the complexity of
the human disease and a way of overcoming this shortfall is to develop in vivo
models of disease using humanised mice. A xenotransplantation mouse model of
human psoriasis has been previously established, where severely immunocompro-
mised mice successfully engrafted human psoriatic tissue (Boyman & H. P. Hefti
[2004]). Clinically relevant features of human psoriasis are reflected in the model
including the complexity of genomic profiles operating within the transplanted
skin grafts. Integration of these genomic profiles with publically available data
leads to highly complex data sets. Deconvolution of these integrated data sets
through network biology principles enables the formulation of new scientific hy-
potheses (Sirota & Butte [2011]) and the identification of unexpected mechanisms
of disease pathogenesis as well potential therapeutic targets.
IL-22 is a key cytokine at sites of peripheral tissues, providing a link between
the immune system and the epithelium (Wolk et al. [2004], Zheng et al. [2007]).
Current in vitro and animal studies suggest that, in psoriasis, IL-22 is primarily
produced by Th22 (Eyerich et al. [2009]) and Tc22 (intra-epidermal CD8+ cy-
totoxic T cells)(Res, Piskin et al. 2010) cells with a less significant contribution
from Th17 and Th1 subsets (Boyman & H. P. Hefti [2004],Conrad et al. [2007]).
Animal data suggest that IL-22 neutralisation is beneficial in inflammatory skin
disease (Ma et al. [2008]). Also, the network biology cytokine-integrative ap-
proach described in section 6.2, has shown that IL-22 is a key player in psoriasis
disease network. However, the precise function of IL-22 in human skin, its kinetics
in disease pathogenesis and usefulness as therapeutic target remain unclear.
Human skin xenograft models were used to show that IL-22 is critical in the
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development and progression of human psoriasis and a promising therapeutic
target. A comprehensive framework for the discovery of biomarkers in human
autoimmune disease was established (Figure 6.5), encompassing computational
and experimental assessment of molecular interactions in whole tissue models of
psoriasis. First, integrates clinical and genomic data, gathered from patients and
tissue samples, to identify a candidate cytokine with a putative role in disease
pathogenesis and therapy for further assessment (Step 1). Gene expression data
pooled from large patient samples generate a disease interactome (network of
inter-connected genes based on similar expression profiles), which is subsequently
used to map gene expression data from experimental Steps 2-5. In Step 2 the
candidate cytokine is injected into a whole tissue model of normal human skin
grafted onto immunosuppressed mice and the resultant pathology analyzed. Step
3 generates a molecular signature of the cytokine-induced pathology in whole skin
tissue. The cytokine molecular signature is mapped onto the disease interactome
placing it in the context of human disease. Step 4 reveals the kinetics of the
cytokine in a whole tissue model of developing human disease and generates a
molecular signature involved in disease development. At step 5 the efficacy of
anti-cytokine therapy is assessed in a clinically relevant model of severe disease
and the anti-cytokine treatment molecular signature identified. At each step,
molecular signatures provide a framework of potential biomarkers for testing in
human disease as part of future clinical trials (dotted lines).
6.3.1 Materials and Methods
6.3.1.1 Data Sources
Normal human skin, from discarded plastic surgery specimens, and psoriasis sam-
ples, from patients attending dermatology clinics, were obtained in accordance
with the Helsinki Declaration and approved by the Institutional review Board
of Guys and St. Thomas NHS Foundation Trust Hospital. Written informed
consent was obtained from all patients and healthy skin donors. Mice. The
AGR129 mice, deficient in type I (A) and II(G) IFN receptors in addition to
being Rag 2-/-, were kept pathogen free throughout the study and individually
housed after experimentation. All animals were maintained and handled under an
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Figure 6.5: Biomarker Discovery Framework (BDF) in human autoimmune disease
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approved license in accordance with the UK Home Office regulations for Animal
Care. Transplantation of human skin (normal (NN) human skin and symptomless
peri-lesional psoriasis(PN)) was performed onto AGR129 mice. Normal human
(NN) skin was allowed to heal for two weeks prior to manipulation while PN skin
was analyzed 14d and 35d after transplantation. The engrafted human skin was
harvested at baseline (day 0), day 14 and day 35, after transplantation for time
course assessment. A model of lesional psoriasis was developed by modifying the
above model. A keratome biopsy from symptomatic lesional psoriasis (PP) skin
was cut into 5mm x 5mm square pieces and glued onto the shaved dorsal aspects
of the AGR129 mice. The skin was allowed to undergo wound healing for 1 week
after which the tissue was manipulated. For analysis of the effect of neutralising
studies the skin grafts were harvested 21 days after transplantation of lesional
psoriasis skin.
Anti-IL-22 monoclonal antibodies were provided by Genentech and infliximab
purchased from Centocor Ortho Biotec Inc. 1 week after transplantation of hu-
man lesional psoriasis skin, the anti-IL-22 moAbs were administered three times a
week for the duration of 2 weeks and given at a dose of 150 g per mouse, whilst In-
fliximab was given, intraperitoneally (ip), at a dose of 100 g per mouse (5mg/kg),
once every two weeks. Three independent experiments were performed with three
individual human psoriasis skin donors. Three mice were used per time point.
The experimental design includes the following datasets: 1. rhIL-22 was in-
jected into normal human skin grafted onto AGR129 mice (NN-22), compared to
skin grafts injected with control normal saline (NN-C). 2. Human symptomless
psoriasis (PN) skin was xenotransplanted onto AGR129 mice and analysed at
different time points (from baseline baseline (day 0 - PNd0), day 14 (PNd14)
and to psoriasiform skin by d35 (PNd35)). 3. A model of lesional psoriasis was
developed. PP skin at baseline (PPd0) had classical features of psoriasis includ-
ing acanthosis and twenty-one days after transplantation of lesional psoriasis skin
(PPd21), a more severe psoriatic phenotype developed. 4. 1 week after transplan-
tation of human lesional psoriasis skin (PP-C), anti-IL-22 monoclonal antibodies
were administered three times a week for the duration of 2 weeks resulting in the
PP-a22 phenotype, which was similar to PN phenotype from histological view
(data not shown)
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The number of samples that used for the analysis after the use of ANOVA
testing to assess the statistical significant samples were: three controls (physio-
logical saline, NN-C), five rhIL22 (recombinant IL-22), ten non-lesional psoriasis
samples (PN) and ten lesional psoriasis samples (PP).
Experiments were done by Dr. Gayathri Perera at Guy’s Hospital.
RNA integrity was assessed prior to performing expression arrays. Human
Ref-6 Expression and Ref-8 BeadChips (Illumina, Ambion) were used to generate
RNA expression data and were scanned with a BeadArray Reader (Illumina, San
Diego, CA).
6.3.1.2 Methods
Differential gene expression analysis was carried out using the MATLAB software
and functions from Bioinformatics Toolbox (http://www.mathworks.com/help/toolbox/bioinfo/).
Genes that were not expressed or had only small variability across the samples
were removed. Students t-test was conducted to identify significant changes for
each gene in their expression values between the different phenotypes. Genes with
p-values < 0.05 and fold change (fch) > 1.5 were considered to be statistically
significant. Over and under expressed genes were further analysed for enriched
Gene Ontology (GO) terms and Kyoto Encyclopaedia of Genes and Genomes
(KEGG) pathways using the log-odds ratio. High ratios indicate higher relative
abundance of a GO term or KEGG pathway compared to the reference set.
The GAIN dataset described in section 6.2.1 was used to build a psoriasis
network. The network was generated based on the co-expression of genes differ-
entially expressed (p-value < 0.05 and fold change > 1.5) in the skin of patients
with psoriasis (PP), compared to those in normal (NN) skin.Gene pairs that
correlated above the 0.7 PCC threshold value were represented in the form of
a network. This psoriasis co-expression network was used as a disease-relevant
reference data set, against which the differentially expressed gene transcripts gen-
erated from the rhIL-22 injected model were assessed.
For functional enrichment analysis of gene sets, the DAVID 6.7 (http://david.abcc.ncifcrf.gov/)
bioinformatics database (June 2011) was used and genes were matched with GO
terms and KEGG pathway terms. The differentially expressed gene list was
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submitted for functional classification in order to explore functionally related
genes together. Functional annotation chart was used to provide gene-term over-
representation analysis and to map the most relevant biological terms associated
with a given gene list. Enriched biological annotation was chosen according to a
statistical threshold.
6.3.2 A tissue specific IL-22 molecular signature
IL-22 is a key cytokine linking cells of the immune system with epithelial home-
ostasis and barrier function (Ouyang et al. [2011]). To elucidate the in vivo
effects of IL-22 in human skin, rhIL-22 was injected into normal human skin
grafted onto AGR129 mice (NN-22), compared to skin grafts injected with con-
trol normal saline (NN-C). NN-22 showed a remarkable phenotype dominated
by epidermal thickening (acanthosis), replicating the epithelial changes seen in
the inflammatory skin pathology psoriasis (Figure 6.6a). Increased acanthosis
(Figure 6.6b) was accompanied by changes in psoriasis-associated markers and
expression of molecular markers associated with psoriasis, such as S100A7 (psori-
asin), serpin B4 and LCN2 (Figure 6.6c). Quantitative real time (RT) rt-PCR
showed no significant change in TNF mRNA expression. IL-17A, IFN-g, IL-19
and IL-20 mRNA were not detected. RNA microarray analysis showed 4251 dif-
ferentially expressed genes between NN-22 and NN-C. Hierarchical clustering of
these genes identified a distinct set of genes associated with IL-22 injected human
skin in vivo (Figure 6.6d), which we designated as the IL-22 in vivo molecular
signature.
6.3.3 IL-22 has novel in vivo properties
A robust molecular network of human psoriasis was generated using patient data
provided through the Genetic Association Information Network (GAIN) (Nair
et al. [2009]), as described in the methods section. Here, the altered mecha-
nisms of the disease comparing with the normal skin tissues were examined. The
co-expression network was generated by assessing pairwise similarity of gene ex-
pression vectors as expressed by the Pearson correlation coefficient (PCC). Gene
pairs that correlated above the 0.7 PCC threshold value were represented in the
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Figure 6.6: A tissue specific IL-22 molecular signature. (A) Histological analysis of
NN skin grafted onto AGR129 mice after treatment with rhIL-22 (NN-22), or (inset)
control (physiological saline, NN-C). H E staining shows increased epidermal thickness
after rhIL-22 injection (scale bars 100m). Data representative of 10 mice with grafts
from 3 independent normal human skin donors. (A) Assessment of epidermal thickness
(acanthosis), in m, of NN-22 and NN-C xenografts. Each data point represents the mean
of 10 random fields from 3 cryosections per mouse, *** p<0.0001. (C) Quantitative
real time PCR analysis of S100A7, Serpin B4, LCN2 and TNF in NN-22 and NN-
C xenografts, *p<0.05, *** p<0.0001. (D) Heatmap showing hierarchical clustering
of differentially expressed genes between NN-22 and NN-C xenografts identifying a
distinct in vivo IL-22 molecular signature. Red represents over-expressed genes and
green represents under-expressed genes (Perera, GK., Ainali, C., et al. In Press)
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form of a network. The resulting molecular network displayed 1614 differentially
expressed genes (nodes) with 25281 interactions (edges). Nodes correspond to
genes and edges represent similar expression profiles of linked genes across dif-
ferent samples (Vidal et al. [2011]). The psoriasis co-expression network (termed
the GAIN-psoriasis molecular network) was used as a disease-relevant molecu-
lar reference data set, against which the differentially expressed gene transcripts
generated by our cytokine injected whole tissue models were evaluated.
The NN-22 molecular signature was assessed within the GAIN-psoriasis molec-
ular network in order to estimate its relevance to the disease. Of the 4251 genes
differentially expressed between NN-C and NN-22, 421 genes mapped onto the
GAIN-psoriasis molecular network (coverage of 26%) (Figure 6.7a). Functional
enrichment analysis of these 421 genes, using the DAVID 6.7 bioinformatics
database (June 2011) and matching the genes with KEGG and Gene Ontol-
ogy (GO) terms (Huang et al. [2009]), identified genes involved in epidermal
remodeling, immune response and Jak/Stat signaling, in keeping with the known
functions of IL-22 (Ouyang et al. [2011]) (Figure 6.7b). Unexpectedly, there
was a set of genes enriched for vascular remodeling (Figure 6.7b), which was
confirmed using human CD31 staining of endothelial cells (data not shown).
6.3.4 Kinetics of IL-22 in psoriasis pathogenesis
Human symptomless psoriasis (PN) skin was xenotransplanted onto AGR129
mice and analysed at different time points. Histology (Figure 6.8a) confirmed
the evolution of PN skin from baseline (PNd0) to psoriasiform skin by d35
(PNd35), as previously published (Boyman & H. P. Hefti [2004], Conrad et al.
[2007]). There was also a significant increase in the number of CD31 staining cells
from PNd0 to PNd14 and PNd35. Unsupervised Principle Component Analysis
(PCA) showed clustering of differentially expressed genes in PN grafts at d14
(PNd14) and grafts at PNd35 compared to baseline PNd0 skin (Figure 6.8b).
There was a clear separation between symptomless skin from evolving psoriasis
as well as an emerging distinction between PNd14 (green dots) and PNd35 (blue
dots), suggesting a similarity in the expression profiles in xenografts at day 14 and
day 35. Next, differentially expressed genes from the in vivo IL-22 molecular sig-
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Figure 6.7: Mechanistic properties of IL-22 molecular signature. (A) The in vivo IL-
22 molecular signature is shown using network analysis of differentially expressed genes
between NN-C and NN-22 grafts (4250 genes) overlaid onto the GAIN-psoriasis molecu-
lar network (26% coverage). Over expressed genes (red dots) and under expressed genes
(green dots). (B) Functional gene enrichment analysis of the differentially expressed
genes between saline injected (NN-C) and IL-22 injected (NN-22) xenografts. The
overall enrichment contribution is specified as a percentage of the relative abundance
of each term in a cluster (Perera, GK., Ainali, C., et al. In Press).
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nature were examined within the evolving psoriatic molecular network, resulting
in 28 and 42 genes at d14 and d35, respectively. Comparison of the the co-
expressed genes from the peri-lesional psoriasis skin model and the in vivo IL-22
molecular signature with the GAIN-psoriasis co-expression network was further
done. There was a temporal increase in the number of in vivo IL-22 molecular
signature genes mapping onto evolving psoriasis genes at d14 (28 genes) and d35
(42 genes) (Figure 6.8c red (over-expressed genes) and green (under-expressed
genes) dots). Quantitative RT rt-PCR determined the temporal expression of
IL-22 with a significant increase at d35 (Figure 6.8d), a relative expression of
at least one order of magnitude greater than other IL-10 family cytokines (IL-19
and IL-20) and psoriasis-associated cytokines (IL-17A, IFN-). Functional gene
enrichment analysis and subsequent hierarchical clustering showed genes involved
in epidermal remodeling, keratinisation and response to wounding in PNd35 (Fig-
ure 6.8e), with a number of genes well known to psoriasis such as S100A7, Defb4,
SPRR2A, serpinb4, serpinb3 and LCE3E.
6.3.5 An extreme phenotype of psoriasis is associated with
a dominant IL-22 molecular signature
In the previous section was shown a critical role for IL-22 in developing psoria-
sis lesions. Further examination of IL-22 in established plaque psoriasis and in
its progression to severe disease showed a dominant molecular signature. An in
vivo model of lesional psoriasis was first establioshed and Human lesional pso-
riasis (PP) skin was transplanted onto immunosuppressed AGR129 mice. PP
skin at baseline (PPd0) had classical features of psoriasis including acanthosis
(Figure 6.9a (i)). Twenty-one days after transplantation of lesional psoriasis
skin (PPd21), a more severe psoriatic phenotype developed (Figure 6.9a(ii)),
exhibiting a significant increase in acanthosis (p ¡ 0.0001, Figure 6.9b), in the
number of T cells (p < 0.001, Figure 6.9b). Differentially expressed genes be-
tween PPd0 and PPd21 were analysed to define the molecular characteristics
of the PPd21 severe psoriasis phenotype. A total of 4363 genes were differen-
tially expressed and 1142 were found to be in common with the in vivo IL-22
molecular signature(Figure 6.9c). Functional gene enrichment identified path-
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Figure 6.8: The kinetics of IL-22 in psoriasis pathogenesis. (A) Time course histo-
logical analysis of symptomless psoriasis skin (PN) grafts over 35 days. H E staining
shows the temporal evolution of psoriasiform histology from baseline (PNd0) to day
14 (PNd14) and day 35 (PNd35) following skin transplantation (scale bars 100m).
Data representative of 3 independent experiments using 3 different human donors. (B)
Principle Component Analysis (PCA) showing the relationship between the common
differentially expressed genes, and the clustering of samples at PNd0 (red dots), PNd14
(green dots) and PNd35 (blue dots). (C) Network analysis of differentially expressed
genes in PNd0, PNd14 and PNd35, compared with the in vivo rhIL-22 molecular signa-
ture (red dots), overlaid onto the GAIN-psoriasis molecular network. (D) Time course
quantitative real time rt-PCR analysis of cytokines in the evolution of psoriasis, (PN
at days 0, 14 and 35), *p<0.05, **p<0.001, *** p<0.0001. Expressed as units of rela-
tive expression, normalized against GAPDH (E) Functional enrichment analysis of the
genes playing a role in PNd35 (Perera, GK., Ainali, C., et al. In Press).
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ways involved in epidermal remodeling, immune response pathways and Jak/Stat
pathways (Figure 6.9d). Vascular remodeling, similar to that obtained with the
in vivo IL-22 molecular signature, was also represented in PPd21 grafts. The
IL-22 gene expression profile of PPd21 was distinct from the PNd35 gene expres-
sion profile with significant representation of IL-22 induced genes associated with
vascular remodeling, immune response and Jak/Stat signaling.
6.3.6 Anti-resposive elemets of psoriasis treatment
Genes differentially expressed in anti-IL-22 treated psoriasis xenografts, IL-22
injected skin xenografts and the GAIN psoriasis molecular signature were in-
tegrated. 1164 genes were differentially expressed between PP-C and PP-a22
with 370 (327 plus 43) genes in common with the in vivo IL-22 signature and
43 of these mapped onto the GAIN-psoriasis molecular network (Figure 6.10).
Functional enrichment of the 43 IL-22 response genes showed under expression
of numerous genes involved in immune response and the Jak/Stat pathway, a
critical component of the IL-22 signaling pathway. 19 genes, that were highly
expressed in NN-22 and PPd21, were also down-regulated after anti-IL-22 treat-
ment (Figure 6.11a, see black box). The PIM1 gene stood out with a low p value
in the IL-22 signature (p=0.00249) and association with the IL-22 and psoriasis
relevant Jak/Stat signaling pathway. Pim-1 had also been associated with vas-
cular remodeling, mainly in the context of arterial hypertension (Meloche et al.,
2011). Network topology of PIM1 revealed connection with STAT3 and S100A7
(Figure 6.10b), suggestive of a possible functional interaction of these 3 genes.
To further determine the role of PIM1, in vitro assays using cytokine-treated
primary skin cells were performed. PIM1 is known to be expressed by a variety
of cell types including keratinocytes (Stewart and Rice, 1995), vascular smooth
muscle cells (VSMCs)(Katakami et al., 2004). Based on experimental and net-
work topology data, PIM1 is potentially induced indirectly in vascular cells via
a mechanism involving S100A7 and its receptor RAGE (Receptor for Advanced
Glycation Endproducts).
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Figure 6.9: A severe psoriasis model. (A) HE staining of (i) PP at day 0 (PPd0),
(ii) isotype injected PP at day 21 (PPd21) displaying a severe psoriasis phenotype.
(B) Quantitative histological assessment of epidermal thickness, acanthosis, measured
in m, in xenografts at PPd0 and PPd21. Each data point represents the mean of
10 measures from 3 random fields per mouse, ** p<0.05, *** p<0.001. (C) The IL-22
related severe psoriasis molecular signature mapped onto the GAIN-psoriasis molecular
network, with over expressed (red dots) and under expressed genes (green dots). (D)
Functional enrichment analysis of severe psoriasis IL-22 molecular signature (Perera,
GK., Ainali, C., et al. In Press).
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Figure 6.10: Venn Diagram of overlapping genes among anti-IL-22 (PP-a22), the
in vivo IL-22 (NN-22) and the GAIN psoriasis molecular signature identifies 43 genes
(Perera, GK., Ainali, C., et al. In Press).
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Figure 6.11: An IL-22 response gene signature identifies PIM1 as an important molec-
ular checkpoint.(A) Heatmap showing gene expression of the IL22 response molecular
signature, expressed as fold change. The black box identifies genes upregulated in
NN-22 and PPd21 and down-regulated upon anti-IL-22 therapy (PP-a22) (B) Network
topology analysis of PIM1 within the GAIN molecular network highlights the S100A7A
STAT3 PIM1 connectivity (broken line box) (Perera, GK., Ainali, C., et al. In Press).
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6.4 Discussion
Recent progress in characterizing human disease at a whole genome level offers the
opportunity to utilise bioinformatics tools to explore disease pathogenesis (Con-
rad et al. [2007]). In section 6.2, molecular topology of psoriasis phenotype was
examined and cytokine-related sub-networks were determined. The molecular
gene-gene network was constructed using the most comprehensive gene expres-
sion data set of psoriasis to date publicly available from the GAIN study (Nair
et al. [2009]). The GAIN-psoriasis molecular network served as a disease-relevant
molecular reference data set for the experimental whole tissue model gene expres-
sion data. IL-20 family cytokines play a major role in psoriatic skin comparing
to normal skin, with an emergence of IL22 and IL24. These findings support
the role of cytokines, as successful disease targets and established relevance in
autoimmunity (Ouyang et al. [2011].
IL-22 was chosen as a candidate cytokine for further experiments, due to
its function as a key effector cytokine linking immune and epithelial cells and
emerging data on its role in psoriasiform skin inflammation (Nawijn et al. [2011]).
Human tissue models were further developed and a novel integrative framework
for biomarker discovery was proposed. As a result, novel cytokine functions and
therapeutic roles in psoriasis were discovered and serine/threonine kinase Pim-1
identified as a mechanistically important molecular checkpoint.
One of the unexpected outcomes of our network analysis of IL-22 injected
human skin was the discovery of a prominent vascular remodeling gene expression
signature. This finding was experimentally validated by demonstrating expanded
and tortuous blood vessels in IL-22 injected human skin grafts. The morphology
of IL-22 induced human blood vessels had striking similarities with those found in
psoriatic skin (Braverman & Yen [1977a], Braverman & Yen [1977b]) and synovia
of psoriatic arthritis (Reece et al. [1999]).
These results highlight the different roles of IL-22 at different stages of pso-
riasis development. An integrative network biology approach was applied to in
vivo models of human disease, paving the way for generating “cytokinomes” of
potential biological and therapeutic relevance for human autoimmune disease.
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6.5 Disclaimer
The experiments were done by Dr. Gayathri Perera at Guy’s Hospital. I am the




Conclusions and Future Research
The increasing flow of biomedical data and the advances in high-throughput ex-
perimental technologies present significant challenges in translational research.
In translational medicine, scientists begin at “the bench” by studying disease
at a molecular or cellular level and continue in the clinical level, at the “bed-
side”. In bioinformatics, computational methods are developed to incorporate
genotypic, phenotypic, and environmental knowledge to gain a better insight into
complex diseases. Bringing together the computational genomics expertise and
the biomedical research knowledge will provide important and novel insights into
the mechanisms of disease pathophysiology.
This thesis has presented different approaches to make use of the biomedical
data in order to effectively transform the information gained from newly generated
data and to produce knowledge. The guiding theory for this research has been
the development and application of machine learning strategies to facilitate the
translational of findings from basic science and enhance human health.
At a first level, classification and feature selection techniques were studied to
examine the prediction performance of a hybrid model and to identify promis-
ing candidate genes with respect to a phenotype of interest. Next, this thesis
introduces a new integer optimisation classification algorithm for disease clas-
sification which for the first time was implemented on a “top-down” approach.
The underlying algorithm was performed in a multi-stage procedure to reveal
functional modules that are closely associated to the phenotype of interest and
relevant to disease pathology. In that way, putative biomarkers, called Phenotype-
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Responsive Genes (PRGs), were identified based on non-overlapping constraints
of the classification procedure.
On another level, the methodological contributions of this thesis focused on
the need for the development of diagnostic and prognostic tools as well per-
sonalized treatment of diseases. Psoriasis was used as an example disease and
biologically meaningful phenotypic classes were generated and molecular varia-
tions among these groups were assessed. Using a tree-based approach, a new
classification pipeline was developed to identify substantial phenotypic groups in
psoriasis, based on patient gene expression profiles. The success of this frame-
work has allowed the establishment of molecular patterns that characterize each
sub-phenotype. This might uncover subtle differences in disease pathogenesis
allowing the emergence of new treatments for psoriatic individuals and further
facilitate the development of personalized treatments for the disease. However,
further analysis and discovery of patterns and associations of transcripts of differ-
ent cell-types (such as T-cells, dendritic cells, keratinocytes) must be done to shed
light on the contribution that different cell types make towards the pathogenesis
of psoriasis. We would then gain a better insight into this unique skin disease
and hopefully, resolve some of the outstanding issues related to its pathogenesis
and treatment.
However, the need to mine, visualise and integrate the different biological data
has motivated the development of network biology (network medicine), which
plays a major role in the understanding of the disease and the molecular mecha-
nisms that drive it. Network inference approaches are valuable for the discovery
of biomarkers associated with a disease. Here, using classification concepts, a
network inference algorithm (NetCFS) was developed. The algorithm uses fea-
ture selection to select a number of genes that are highly correlated with the
phenotype of interest so as to generate n different regression problems. The goal
here is to identify sub-networks within the regulatory network that change be-
tween physiological and pathological stages of the disease. For this reason the
algorithm was compared to co-expression network inferred be Pearson Correla-
tion Coefficient and has been shown that can infer scale free networks exploiting
static steady-state expression data and can identify hub genes that could be po-
tential targets. Compared to GENIE3, this thesis applied the NetCFS to the
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human genome and this raise some computational issues, due to the large dimen-
sionality. Future advances of the algorithm should aim to improving significantly
the network predictions and potentially applying it to time-series data as well
genotyping data in order to capture the integrative perspective.
Due to an explosion in the search for putative disease biomarkers, during this
work, some novel applications of network biology were employed for skin diseases;
melanoma and psoriasis. An identification of biomarkers of human disease, and
specifically those predictive of response to therapy, is an ideal of personalised
medicine. In melanoma, exploiting protein-protein interaction data from public
databases, the current study, described in Chapter 4, has shown that the newly
generated IgE and IgG molecular signatures had different effect in tumor growth
and were related to different pathways. Further, to explore the clinical relevance
of IL-22 in psoriasis, a novel framework was implemented for interrogating cy-
tokine pathways in human disease, by combining disease relevant models and
integrative network analysis.Using a network biology approach, the in vivo effect
of IL-22 has been shown on normal human skin and its kinetics in human psori-
asis pathogenesis, and in disease progression. This integrative medicine systems
analysis generated IL-22-related gene signatures, which could potentially identify
subgroups of responders or not to anti-IL-22 therapy.
In this work, expression data were integrated with other biological public avail-
able data for integrative modeling. However, integrating genotypic data with gene
expression may potentially associate genetic factors with the downstream changes
in phenotype. For example, previously have been demonstrated that integration
of Single Nucleotide Polymorphism (SNP) data enables the better understanding
of the functional eect of SNPs in the structure and dynamics of biological net-
works (Bauer-Mehren et al. [2009]). Thus, trait-specific transcriptional networks
of disease will provide the basis for comparative network analysis, where two
networks relating to different disease states are handled simultaneously, in order
to derive important changes unambiguously. Such analyses will reveal the criti-
cal gene variants in differentiating between disease groups or patient classes and
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Pseudocode for Random Forest Algorithm
Input: Training sets (x, y), Machine Learning Algorithm, Integer j (number
of iterations)
Output: gn(x,N), tree classifier. Export Random Forest features: confu-
sion matrix, variable importance, Out Of Bag (OOB) error, proximity matrix.
For (i = 0; i < j; i+ +) do
Random Bootstrap Sampling with replacement of N observations
Bootstrap sample Dn(N) is generated
Foreach sample calculate unpruned tree model. For M input variables, select
m << M from the original training sets and at each node the best split on the
m is used to split the node. Generate a bagging classifier as g(m)n(X,Nm, Dn)
which is used as the voting classifier.
Foreach node do (i) the splitting using Gini Index (GI), (ii) sample m predictor






NetCFS algorithm is described here in more details by explaining its functions in
java, WEKA API and Matlab as used from GENIE3.
Java Classes
Two dimensional arrays were used for a number of variables to store information
regarding the networks.
1. public double datasetmatrix[][];: This array consists of a representation of
the training dataset where rows represent observations and columns correspond
to variables
2. public double rfmatrix[][], genematrix[][]; : N × N adjacent matrices,
where N represents the number of genes in the training set. Genematrix keep
the results from CFSsubseteval and rfmatrix represents the matrix obtained from
Matlab
3. public double genenetwork[][]; : Similar as Genematrix but it stores the
final structure of the gene expression network.
4. public void readarff () : Function that is used to open a .arff file (training
set) to be parsed by weka object instances.
5. public void generate(); generate(String[] attributelist) : Using CFS-
subsetevaluation from Weka API, a gene network is generated. A gene is selected
as the predictor, class of the dataset, and next an object of type “attribute se-
lection” from the WEKA API is created. This object is set to generate feature
selection using the CFSsubset evaluation. The result of the feature selection is
stored in an integer array holding the indexes of the genes selected. This array
is then used to update the array genematrix.
6. public void generatewithrandomjungle( String rjdir, String tempre-
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sultdir, String csvdir) : This method is used to calculate the weights (links)
using random jungle. rjdir: random jungle executable directory,tempresultdir:
directory storing the output and csvdir: directory to put the dataset in csv for-
mat. This method calls random jungle for each gene in the dataset.
7. public void exportnetworkcsv(double[][] resultmatrix, String csvdir):
Function to export the gene expression network in csv format. Each row corre-
spond to an edge and is described by three columns: the target node, the source
node and the weight
8. public void generatehubs(double [][] tempgenematrix, String tem-
pdir): Function to identify the hub genes. For directed networks the in-degree
and out-degree edges of every node are calculated. Another version of this method
have been created to find degree of undirected networks.
9. public void pccoexpressionnetwork(double cutoff, double negative-
cutoff): Function to generate a gene network using Pearson Correlation Coef-
ficient (PCC). An adjacency matrix is created containing the correlation values
between all genes. An undirected network is constructed keeping only the corre-
lation value between two genes that is greater than a cut off being applied.
10. public void filterduplicates(): Function to remove duplicated edges by
looking at every location in the adjacency matrix if item at (i, j) == item(j, i)
and their value is equal to 1. In this case the funtion removes the edge which has
the smallest value calculated from GENIE3.
11. public void checksymetry(double[][] network) Function to count the
number of edges which are symmetrical (edges which point to same nodes but
differ in direction). The parameter is used to point to the network.
12. public void comparehubs (double [] list1, double[] list2, double cut-
off, String tempdir) Comparison of hubs derived from two different networks.
This method accepts two lists which contain the degree of each node. First the
hubs of the list 1 are derived by selecting nodes which have number of neighbours
greater than a cutoff value. Then the function exports the hubs to a CSV file
and their respective number of degrees in the second list.
GENIE3
Here is given a brief description of the methods implemented in (Huynh-Thu
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et al. [2010]) for GENIE3 and used by the algorithm presented in this thesis.
function VIM = genie3(exprmatrix,inputidx,treemethod,K,nbtrees)
This function is used to extract the weights for the construction of a network.
Each setting has a different role: exprmatrix: A matrix where rows are samples
and columns represent variables. inputidx: The list of genes which will be used
to create the network. When the list is empty, all the genes are used. treemethod:
type of the tree that was used K: number of features used in the splitting proce-
dure nbtrees: number of trees created in the classification
function vi = genie3single(exprmatrix,outputidx,inputidx,treemethod,K,nbtrees)
Function to return a list of rankings for all genes with respect to the gene selected
as a predictor. Parameters exprmatrix,inputidx,treemethod,K and nbtrees have
the same function as in the function VIM, while outputidx is used as an index to
the feature which will be used as the class/predicted value.
WEKA API
To do the classification and feature selection, WEKA API version 3.6 was used.
This version contains a number of classes describing different objects and algo-
rithms which can be accessed from a java application. A brief description of the
items that were used is given below:
Object Instances
This object is used to keep the training datasets. Once the .arff file is read by the
application it is automatically parsed and stored into an object of type instance.
Each sample is stored as an object instance containing an array with the values
for all variables.
Package classifiers
This package contains a number of classes which can be used as classifiers. These
classes are subdivided by the classifier type which includes trees, functions and
lazy methods. The classes name represents the algorithm they implement: Ran-
dom Forest, Bagging, AdaBoostM1 (Boosting), LIBSVM (implementation used
to generate support vector machines) and IBK (implementation of the K-nearest
neighbour classifier).
Class Evaluation




This object is used to do attribute selection on a given training dataset. All
the different feature selection techniques are implemented in the package named
attribute selection.
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